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S U M M A R Y  
Liver transplantation is currently the only established, viable treatment for 
metabolic liver diseases.  However, there is an acute shortage of donor organs, thereby 
fuelling researches on liver tissue engineering — such as development of bioartificial 
liver (BAL) devices or cell-based transplantation therapies.  Nonetheless, both 
developments are still in “infancy to adolescence” stage as the most significant 
challenge of successfully maintaining viable and functional hepatocytes outside of 
native liver environment has not been overcome.  Isolated hepatocytes start to spread 
and proliferate under suboptimal culture conditions, losing most of the characteristic 
differentiated hepatic functions within three to four days. 
To circumvent this challenge, several tissue engineering approaches have been 
advocated to modulate the culture parameters in a bid to mimic the microenvironments 
in vivo.  These approaches include: 
(1) Culturing in three-dimensional organisation; 
(2) Culturing on bioactive surfaces; 
(3) Culturing under flow conditions; and 
(4) Culturing with several types of supporting cells include liver-derived and  
non-liver-derived cells. 
In light of these approaches and through a combination of these approaches, we 
proposed to develop a strategy — which entailed two different types of scaffolds, 
unstructured versus structured — to maintain a mass of highly functional, viable 
hepatocytes which can preserve their differentiated functions for long-term cultivation. 
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The first novel scaffold developed in this study was an unstructured one with a 
three-dimensional architecture.  A 3D structure was being considered and 
contemplated in this study because a 3D scaffold is capable of supporting a mass of 
cells, thereby improving the functionality of BAL devices.  Leveraging on successfully 
surface-modified poly(lactic-co-glycolic acid) (PLGA) microfibres — through 
hybridization and collagen conjugation, a hybrid scaffold consisting of random-
blended, collagen-grafted PLGA microfibres and crosslinked collagen was developed.  
Compared to collagen sponges per se, it was found that this novel hybrid scaffold had 
improved physical and mechanical properties as well as higher cellular affinity.  
Moreover, through a perfusion coculture experiment in a dual-chamber bioreactor, the 
results showed that hepatocytes cocultured with hepatic stellate cells (HSC-T6) in this 
hybrid scaffold exhibited enhanced differentiated functions (such as albumin secretion 
and urea synthesis) versus the monoculture system where hepatocytes alone were 
cultured. 
The second novel scaffold entailed a well-defined, three-dimensional structure 
which was exposed to an intra-tissue perfusion (ITP) system.  Previous studies have 
shown that cell behaviour was influenced by scaffold architecture.  Thus, to the end of 
evaluating the clinical applicability of this novel structured scaffold, it was critical that 
positive and affirmative cell responses were elicited.  Furthermore, the ITP system 
requires microneedles to serve as delivery conduits and a scaffold with a  
well-defined structure facilitates penetration by a microneedle array. 
The second hybrid scaffold was developed via gamma-induced polymerisation of 
collagen in three-dimensional, porous polycaprolactone (PCL) scaffold preformed by 
fused deposition modelling technique (FDM).  First, the surface of PCL scaffold was 
uniformly grafted with poly (acrylic acid) by gamma induction in a hierarchical order, 
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followed by collagen conjugation.  Next, collagen-conjugated scaffold was immersed 
in a collagen solution and subjected to gamma-induced polymerisation.  After  
freeze-drying, a hybrid scaffold composed of aligned PCL microfibres and tortuous 
collagen sponge embedded between microfibres was formed.  Cell seeding experiment 
revealed better cell adhesion affinity on the surface of this hybrid scaffold versus the 
synthetic polymer scaffold.  As for the maintenance of differentiated functions 
expressed by the hepatocyte culture in this PCL-collagen hybrid scaffold, it was 
examined through a perfusion culture in an intra-tissue perfusion system where the 
scaffold was penetrated with a microneedle array through defined interspaces of the 
scaffold.  The results indicated enhanced differentiated functions — such as albumin 
secretion and urea synthesis — throughout the entire culture period. 
In conclusion, two different hybrid scaffolds were successfully fabricated: an 
unstructured one comprising random-blended, collagen-grafted PLGA microfibres and 
crosslinked collagen (PLGA-collagen), versus a structured and well-defined one which 
comprised collagen sponge and a collagen-grafted, three-dimensional scaffold 
preformed by FDM with gamma-induced collagen polymerisation (PCL-collagen).  
Nonetheless, both types of hybrid scaffolds exhibited superior physical and mechanical 
properties than their individual counterparts, and their chemical and biological 
characterisation illustrated better cellular affinity. 
Taken together, the encouraging results obtained in this study highlighted the 
optimistic applicability of these scaffolds for liver tissue engineering.  It should be 
mentioned that the facile and effective approaches rendered in this thesis successfully 
synchronised natural and synthetic polymers, as well as perfusion-based hepatocyte 
coculture with HSC-T6.  As such, the herein-developed scaffolds were able to 
maintain a mass of highly functional, viable hepatocytes which could preserve their 
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differentiated functions for long-term cultivation— thereby paving the way for 
efficient development of BAL devices and cell-based tissue construct transplantation 
therapies in the future. 
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1.1 BACKGROUND 
Liver is the largest visceral organ.  It is involved in almost all the biochemical 
pathways in human body [1,2].  By virtue of the important roles which the liver plays, 
liver diseases can therefore bring about serious detrimental effects on the human body.  
To date, diseases which can cause serious damage to the liver include Wilson’s disease; 
hepatitis (an inflammation of the liver), liver cancer and cirrhosis (a chronic 
inflammation that progresses ultimately to organ failure). 
Currently, orthotopic liver transplantation is the major treatment procedure for 
patients with end-stage of liver diseases (liver failure) to resume a normal life [3,4].  
However, this treatment is limited by severe scarcity of donor livers [5,6].  In the last 
ten years, the demand for liver transplantation has increased dramatically.  But, the 
supply of available livers from organ donors does not match this increasing demand.  
According to the United Network for Organ Sharing (UNOS) statistics, approximately 
17,413 persons with end-stage liver disease are on the liver transplantation waiting list 
as of September 2005, while 6,168 transplantations were performed in 2004.  In the 
same year, 1,811 persons died while waiting for liver transplant, with a waiting list 
mortality rate of 10%.  As of 29 June 2007, more than 4,200 of them have been 
waiting five years or longer.  Indeed, this gap between demand and availability has 
increased the average waiting time for liver transplantation.  Furthermore, more and 
more patients are dying while waiting for livers to become available. 
Driven by the increasing gap between liver donation and transplantation demand, 
biomedical researchers have sought to develop reliable alternative treatments that 
replace the vital functions of liver temporarily or permanently.  Amongst which are (1) 
bioartificial liver (BAL) devices and (2) cell-based tissue construct transplantation 
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therapies aimed at transplanting constructed surrogate tissues which contain isolated 
liver cells for liver regeneration. 
However, after 40 years of evolution, the developments of both BAL devices and 
cell-based tissue construct transplantation therapies are still in “infancy to 
adolescence” stage. This is chiefly because the most significant challenge that how to 
maintain mass of viable and functional hepatocytes (major functional cells in liver) 
outside of native liver environment for long term culture has not been overcome. [7−9].  
Isolated hepatocytes start to spread and proliferate under suboptimal culture conditions, 
losing most of the characteristic differentiated hepatic functions within three to four 
days [10,11], thereby rendering BAL devices inefficient or constructed surrogate 
tissues unreliable.  Against this background, it is critical to arrive at a strategy that 
preserves a mass of highly functional viable hepatocytes for long-term cultivation in 
vitro, to the end of developing efficient BAL devices and reliable cell-based tissue 
construct therapies. 
In recent tissue engineering and molecular biology studies, it was discovered that a 
cell’s fate depends indispensably on its culture niche [12−16].  Briefly, a cell’s life is 
determined by various local clues, such as its physical and chemical relationships with 
the neighbouring cells, its polarised interactions with the adjacent extracellular matrix, 
as well as nutrient/waste transfer around it.  Consequently, several research groups 
have made efforts to study the relationship between maintaining the highly functional, 
viable hepatocytes in vitro and modulating culture parameters to mimic the 
microenvironments.  The following is a brief overview of their research findings: 
(1) Culturing in three-dimensional (3D) organisation.  Hepatocytes are 
anchorage-dependent cells and require a substrate for survival, reorganisation, 
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proliferation, and functions.  Several studies have focussed on substrates and their use 
in devices for the retention of highly functional viable liver cells for long-term 
cultivation [17−21].  Their objective was to construct reliable surrogate tissues using 
synthetic polymer substrates.  Results from their research studies indicated that 
hepatocytes cultured in polymer substrates showed considerable potential in retaining 
differentiated functions. 
(2) Culturing on bioactive surfaces.  These substrates not only provide a surface 
for cell adhesion for the hepatocytes, but also wield a profound influence on the 
modulation of cell shape and gene expression, relevant to cell growth and liver-specific 
functions through the diversity of specific cell surface molecular interactions [15,22].  
On this note, synthetic polymers have been a subject of interest due to these 
advantageous characteristics: acceptable mechanical strength, well-controlled 
degradation rate, and malleability into many shapes for use as cellular substrates.  
However, cell attachment on the surface of synthetic polymers is relatively poor when 
compared with natural extracelluar matrix (ECM)s such as collagen [23].  To 
overcome this drawback, physical or chemical immobilisation of natural polymers or 
bioactive molecules on the surface of synthetic polymer substrates on where the 
hepatocytes were cultured were adopted.  It has been reported that hepatocytes cultured 
thus showed better maintenance of hepatic functions than those cultured on synthetic 
polymer substrates without immobilisation [24−26]. 
(3) Culturing under flow conditions.  To successfully replace the vital functions 
of a liver by BAL device or transplanted surrogate tissue, the critical factor lies not 
only in the maintenance of hepatocyte functions, but also the amount of hepatocytes 
cultured in the BAL device or constructed surrogate tissue.  On this score, a few 
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factors have been identified for restricting the amount of hepatocytes in BAL devices 
or constructed surrogates such as mass transfer of oxygen or nutrients and waste 
exchange around the highly metabolically hepatocytes.  In the quest for producing 
mass hepatocytes in vitro, researchers have studied the influence of flow in bioreactors 
on the maintenance of cell number in configured substrates [27−31].  Initial data 
suggested that hepatocytes cultured under flow conditions resulted in better 
maintenance of cell number, as well as higher cell functions compared with 
hepatocytes cultured under static conditions. 
(4) Culturing with several types of supporting cells including liver-derived and 
non-liver-derived cells.  Cells are inherently sensitive to their neighbours, including 
physical and chemical interactions.  As such, cocultivation of hepatocytes with 
nonparenchymal cells has been demonstrated to preserve and modulate cell growth, 
migration, and/or differentiation in vitro [32−35].  In particular, enhancement of 
hepatic functions can occur through paracrine signalling via TGF-β1 or static coculture 
of hepatocytes and hepatic stellate cells without direct cell-cell contact [36−38]. 
To date, all the abovementioned studies (1) to (4) are still in their early stages.  
Their achievements have not been proven efficacious and were neither applied in a 
clinical setting.  Nonetheless, leveraging and building upon these obtained findings, we 
developed a strategy to preserve a mass of highly functional, viable hepatocytes for 
long-term cultivation in vitro. 
The novel strategy involved developing new scaffolds by introducing natural 
bioactive polymers on the surface of sourced synthetic polymers through surface 
modification.  Then, hepatocytes were cultured in these novel scaffolds under different 
culture parameter conditions in a perfusion culture system — namely, coculture or 
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intra-tissue perfusion (ITP).  The principles and rationales behind the proposed 
strategy were as follows: 
Â Surface modification of synthetic polymer by collagen grafting would stabilise 
the collagen sponges embedded in the porous synthetic polymer substrate, while 
collagen grafted on the surface of synthetic substrates would improve cell adhesion. 
Â Through coculture techniques with hepatic stellate cells (HSC-T6) without 
direct contact, hepatocytes would exhibit enhanced hepatic functions such as albumin 
secretion, urea synthesis and cytochrome P450 enzymatic activity versus a 
monoculture condition where hepatocytes alone were cultured. 
Â Evoke efficient mass transfer of oxygen and nutrients which are key to mass 
production of functional viable hepatocytes. 
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1.2 OBJECTIVES 
The present research aimed to develop a novel strategy to preserve a mass of 
highly functional, viable hepatocytes for long-term cultivation in vitro.  It is hoped that 
this will contribute to the development of efficient BAL devices and reliable cell-based 
tissue construct transplantation therapies in the future.  Accordingly then, the specific 
areas of interest of this study were as follows: 
1: To investigate cell attachment in novel hybrid 3D scaffolds which were 
fabricated using synthetic polymer scaffolds, where the latter were subjected to surface 
modification by collagen grafting. 
Hypothesis: The benefits of both a synthetic polymer scaffold and collagen can be 
realised in a hybrid scaffold, thereby providing a cell-affinitive surface for hepatocyte 
attachment. 
2: To investigate the effects of hepatic stellate cells (HSC-T6) on the liver-specific 
functions of liver cells over a 9-day coculture period, by coculturing hepatocytes with 
HSC-T6 in the hybrid scaffold in a dual-compartment bioreactor. 
Hypothesis: Co-existence of hepatocytes and HSC-T6 in separate hybrid scaffolds 
is necessary for expression of liver functions.  Diffusion of soluble chemical clues 
secreted by HSC-T6 served to enhance the maintenance of hepatocyte functions. 
3: To investigate the effects of intra-tissue flow perfusion on liver-specific 
functions of the hepatocytes over a 9-day culture period, by means of a perfusion 
culture of hepatocytes in the hybrid 3D scaffold in an ITP system. 
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Hypothesis: Less mass transfer impedance of distribution on nutrients or oxygen 
and waste exchange in ITP system, improving the maintenance of liver-specific 
functions of hepatocytes cultured in a thick scaffold system. 
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1.3 SCOPE OF DISSERTAION 
This whole thesis is composed of seven chapters and organised as follows: 
Chapter 1 gives an introduction of the research background, objectives and scope 
of dissertation. 
Chapter 2 is a literature review on the physiology of liver and liver failure, and 
current liver failure treatment strategies, tissue engineering applications on liver failure 
treatment, a survey of the prior arts of materials and scaffolds fabrication for tissue 
engineering, and the state of the art of BALs and cell-based tissue construct 
transplantation therapies for liver tissue engineering. 
Chapter 3 is on fabrication of bioactive random blending 3D PLGA-collagen 
hybrid scaffold and characterisation of cell attachment of hepatocytes. 
Chapter 4 is on the perfusion coculture of hepatocytes with HSC-T6 in PLGA-
collagen scaffold of dual-compartment bioreactor, in which the effects of HSC-T6 on 
the maintenance of hepatocyte functions are evaluated. 
Chapter 5 is on fabrication of bioactive structure defined 3D PCL-collagen hybrid 
scaffold with gamma irradiation and characterisation of cell attachment of hepatocytes. 
Chapter 6 is on the perfusion culture of hepatocytes in bioactive PCL-collagen 
scaffold in an intra-tissue perfusion bioreactor, and thereby evaluate the application 
feasibility of PCL-collagen scaffold in BAL devices. 
Chapter 7 provides a conclusion on this study as well as recommendations. 
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2.1 INTRODUCTION 
To determine a methodology that can be successfully applied for liver tissue 
engineering, it is essential to understand the cellular and extracelluar components of 
the liver.  To develop a novel scaffold that can act as an extracelluar matrix for 
hepatocyte cultivation, it is important to gain insights into the liver’s functions, in 
particular the effects of various stimulations on hepatocyte’s functions.  Finally, in the 
context of this liver tissue engineering study, the principles of tissue engineering and 
the status of current liver tissue engineering research are reviewed in this chapter. 
2.2 LIVER AND LIVER FAILURE 
2.2.1 Liver anatomy 
The liver is the largest visceral organ in the human body.  It weighs about 2.5% of 
the body weight.  It is wedge-shaped and is covered by a network of connective tissue 
(Glisson’s capsule) as shown in Figure 2.1.  The liver is divided by fissures into four 
lobes: right, left, quadrate and caudate lobes.  These lobes are further divided into 
thousands of much smaller units known as liver lobules.  Each lobule is separated from 
each other by an interlobular septum made out of extracelluar matrix (ECM) [1].  The 
liver is among the few internal human organs capable of natural regeneration of lost 
tissue.  Loss of hepatic tissue by surgical removal or from the action of toxic 
substances triggers a mechanism by which the liver cells begin to divide, continuing 
until the original mass of tissue is restored [2].  It is noteworthy that as little as 25% of 
remaining liver can regenerate into a whole liver again. 
The liver holds about 13% of the body’s blood supply at any given moment.  There 
are two distinct sources that supply blood to the liver: (1) oxygenated blood flows in 
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from the hepatic artery branching from the celiac trunk to the liver at a flow rate of 800 
mL/min; and (2) nutrient-rich blood flows in through the hepatic portal vein from the 
spleen, pancreas and intestines for detoxification and processing at a flow rate of 
1000−1200 mL/min [3].  Blood flows radially from the hepatic triads through the 
sinusoids, where exchange of nutrients, toxins and metabolites takes place on the 
basolateral side of the hepatocytes, before it drains into the central vein.  Bile 
canaliculi are located in between tight junctions at the apical side of the hepatocytes 
[4]. 
 
Figure 2.1  Diagram of liver in the human body 
(http://www.ariess.com/s-crina/liver-anatomy.htm) 
2.1.2 Liver cells 
Cells in liver can be classified as parenchymal and non-parenchymal cells.  
Parenchymal cells are hepatocytes, which are complex and highly differentiated cells 
of epithelial origin.  They are the predominant cell type in the liver, comprising 60% of 
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the total cell number and 80% of the total liver volume.  Hepatocytes are polyhedral 
with six or more surfaces, and with a size of 20−30 μm in diameter [5].  Almost all the 
liver functions, which include synthesis, biotransformation (i.e., detoxification) and 
metabolic reactions, are characteristically carried out by the hepatocytes. 
Hepatocytes in the liver lobule are radially disposed and are arranged into plates, as 
shown in Figure 2.2.  Spaces between those plates through which blood flows are 
called sinusoids that are assumed to be microvascular systems in liver tissue.  
Sinusoids comprise liver sinusoidal endothelial cells (LSEC), Kupffer cells and stellate 
cells, which are non-parenchymal cells [4]. 
LSECs account for about 15−20% of total number of liver cells, and their presence 
causes liver sinusoids to be regarded as unique capillaries.  Hepatic endothelial cells 
differ from other endothelial cells due to the presence of open pores or fenestrae that 
are devoid of diaphragms.  LSEC fenestrae are dynamic structures that act as a sieving 
barrier to control the extensive exchange of material between the blood and the liver 
parenchyma.  It should be highlighted that LSEC have specific physiological role in 
contrast to vascular endothelial cells.  They perform special functions like filtration, 
regulation of sinusoidal blood flow and endocytosis [3]. 
Kupffer cells account for about 10% of total liver cells.  They are located on the 
inside of sinusoidal wall and they protrude into the sinusoidal lumen.  Kupffer cells are 
predominantly located in the periportal region, which may be the best location to be 
associated with endocytosis [5]. 
Another type of sinusoidal cell is the hepatic stellate cell (HSC).  HSCs account for 
about 3.6−6% of total number of liver cells.  Besides Vitamin A storage, HSC also 
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regulates liver growth via extracelluar matrix production, growth factor synthesis, 
matrix remodelling, cytokine production and modulation of sinusoidal porosity [6-9]. 
 
Figure 2.2 (A) Schematic drawing of the structure of liver; (B) Three-dimensional aspect of a 
normal liver  [1] 
2.1.3 Liver functions 
Most of the physiochemical and biochemical processes in the human body take 
place in the liver.  Some of the more well-known functions are briefly described below. 
(1) Regulation and synthesis 
Bile production.  Bile is synthesised by hepatocytes and secreted into biliary ducts.  
The major components of bile include cholesterol, phospholipids, bilirubin (a 
metabolite of red blood cell haemoglobin) and bile salts.  In particular, bile salts act 
as “detergents” that aid in the digestion and absorption of dietary fats in the small 
intestine.  Liver damage or obstruction of a bile duct can lead to cholestasis, 
steatorrhea and jaundice [10]. 
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Protein production.  Most proteins in blood are synthesised and secreted by the 
liver.  One of the most abundant serum proteins is albumin, as shown in Figure 2.3.  
Human liver synthesises about 3 g/day of albumin.  Albumin plays an important 
role in maintaining plasma volume and tissue fluid balance.  This is achieved by 
maintaining the colloid osmotic pressure of plasma.  Plasma albumin also plays a 
pivotal role in the transport of many substances in blood, such as free fatty acids 
and some drugs.  Impaired liver function that results in decreased serum albumin 
synthesis may lead to edema.  Moreover, albumin secretion is a good marker for 
protein synthesis because it requires liver-specific gene expression and intact 
translational and secretory pathways in the cells [4]. 
 
Figure 2.3  Synthesis of albumin and urea in liver [4] 
(2) Storage 
Liver is designed to store important substances such as glucose (in the form of 
glycogen).  The liver also stores fat-soluble vitamins, folate, vitamin B12, and 
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minerals such as copper and iron.  However, excessive accumulation of certain 
substances can be harmful.  For example, patients with an inherited condition 
known as Wilson’s disease cannot secrete copper into bile normally and usually 
have a low blood level of the copper-binding protein, ceruloplasmin.  Retained 
copper accumulates in the liver (leading to cirrhosis) and in the central nervous 
system (resulting in neuropsychiatric symptoms). 
(3) Ammonia clearance 
Ammonia plays a pivotal role in nitrogen metabolism.  It is derived from 
protein degradation and nucleic acid catabolism.  Ammonia metabolism is a major 
function of the liver, which has an ammonia concentration of about 0.7 mmol/L — 
10 times higher than that in plasma.  In the presence of severe liver disease, 
ammonia accumulates in the blood because of two factors: decreased blood 
clearance and decreased ability to form urea.  High circulating ammonia levels are 
highly neurotoxic and can lead to several distinct neurological disorders including 
coma.  Besides brain coma and seizures, elevated ammonia levels may also lead to 
hepatic encephalopathy.  Liver cells thus synthesise urea to reduce ammonia 
concentration in blood, and urea is ultimately excreted from body via the kidneys, 
as shown in Figure 2.3. 
(4) Xenobiotic metabolism 
Xenobiotics are compounds that are foreign to the human body, such as drugs 
or toxins.  Most xenobiotics are introduced into the body by food consumption.  
The kidney is assigned to dispose of these substances ultimately.  However, for 
effective elimination, the xenobiotics must be made hydrophilic before they reach 
the kidney.  Against this background, the liver plays an important role in 
converting xenobiotics into hydrophilic compounds (biotransformation). 
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In the liver, reactions leading to the biotransformation of xenobiotics are 
traditionally classified into two phases (Phase I & II).  In Phase I, the parent 
compound is biotransformed into more polar compounds by the introduction of one 
or more polar groups, such as hydroxyl (OH) and carboxyl (COOH).  Oxidation of 
hydrophobic compounds is the most commonly encountered biotransformation 
process. An enzyme that contributes significantly to xenobiotic/drug 
biotransformation is NADPH-cytochrome P450 reductase (or known as 
cytochrome P450). In Phase II, oxidation products are converted into final 
hydrophilic substances to allow for rapid elimination.  This involves the 
conjugation of the toxic compound with a variety of amino acids and nutrients, 
including glutathione, sulphur, glucuronic acid and glycine, as well as methionine, 
cystine and taurine [4]. 
(5) Bilirubin metabolism 
Bilirubin is the breakdown product of haemoglobin (the protein inside red 
blood cells).  The spleen, where old red cells are destroyed, releases “un-
conjugated” bilirubin into the blood.  The liver efficiently takes up bilirubin and 
chemically modifies it to “conjugated”, or water-soluble, bilirubin which can be 
excreted into bile.  High concentration of bilirubin results in jaundice, a yellow 
pigmentation of the skin and eyes. 
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2.1.4 Liver failure 
Liver failure, another name for end-stage liver disease, is a condition in which the 
liver is unable to perform its normal synthesis and metabolic functions [11, 12].  Two 
types of liver failure are recognised: (1) Acute liver failure (ALF) and (2) Chronic liver 
failure (CLF).  To date, risk factors identified for causing liver failure are: 
Â Cirrhosis of the liver 
Â Hepatitis (A, B, C, D and E) 
Â Certain toxins/chemicals/drugs (aspirin, nicotinic acid) 
Â Alcoholism 
Â Liver cancer 
If detected early enough, ALF caused by an overdose of acetaminophen can 
sometimes be treated and its effects reversed.  Likewise, if a virus causes liver failure, 
supportive care can be given at a hospital to treat the symptoms until the virus runs its 
course.  In these cases, the liver can sometimes recover on its own [12]. 
For CLF which is a result of long-term deterioration, the initial focus may be on 
saving whatever part of the liver that is still functioning.  If this is not possible, the 
only way to save a patient’s life is to receive a transplant[13].  Liver transplants are a 
routine procedure that is often successful.  However, such treatment is limited by a 
severe scarcity of donor livers [14]. 
In the last ten years, the demand for liver transplantation has increased dramatically.  
However, the supply of available livers from organ donors has not matched this 
increasing demand.  According to the statistics released by United Network for Organ 
Sharing (UNOS), approximately 17,293 persons with end-stage liver disease are on the 
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liver transplantation waiting list.  As of June 2007, more than 4,000 of them have been 
waiting for five years or longer (Table 2.1).  This gap between demand and availability 
has increased the average waiting time for liver transplantation.  Furthermore, more 
and more patients are dying while waiting for livers to become available.  Besides the 
availability crisis, liver transplantation is expensive.  A liver transplant for a child costs 
approximately US$150,000 to US$200,000, while immunosuppressive medications 




Table 2.1  Organ transplantation waiting list in USA as of 29 June 2007 
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2.2 TISSUE ENGINEERING AND APPLICABILITY IN LIVER 
FAILURE 
2.2.1 Overview of tissue engineering 
A commonly applied definition of tissue engineering, as stated by Langer and 
Vacanti, is “an interdisciplinary field that applies the principles of engineering and life 
sciences toward the development of biological substitutes that restore, maintain, or 
improve tissue function or a whole organ” [15].  The ultimate goal of tissue 
engineering is to replace or restore complex human tissue function.  Tissue engineering 
is fuelled in part by donor organ scarcity, as well as by technical difficulties, financial 
expense and complex labour in intensive care associated with conventional organ 
transplantation.  In contrast, tissue engineering products are more readily available 
than donor organs because their availability is usually resolved using cell expansion 
culturing techniques.  They are also more cost-effective because permanent 
immunosuppressive medication during post-transplantation care is not needed [16]. 
For tissue engineering, the basic components are the scaffold, cells and tissue 
culture, as shown in Figure 2.4. 
(1) Scaffold.  This serves as an artificial extracelluar matrix or a substrate for cell 
adhesion.  It provides an architecture on which seeded cells can organise and develop 
into the desired organ or tissue prior to implantation[13].  The scaffold provides an 
initial biomechanical profile for the replacement tissue until the cells produce their 
own ECM. 
(2) Cells.  Cells are harvested and incorporated into scaffolds for tissue building.  
In many case, cells are loaded into scaffolds as seeds to grow, differentiate, proliferate 
and form functional tissue ultimately [15]. 
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(3) Tissue culture.  This refers to the configuration and environmental conditions 
provided for cells to grow, differentiate and proliferate. 
 
Figure 2.4  Basic components of tissue engineering applications[17] 
 
Regarding to the main focuses of this study, the basic components: scaffold and 
tissue culture in tissue engineering are described in detail as follow:  
2.2.2 Scaffolds  
2.2.2.1 Scaffold material selection 
Material selection is a critical factor in tissue engineering.  The most prominent 
role played by materials is the creation of 3D scaffolds with initial mechanical integrity 
to either guide tissue growth into cellular implant, or provide cell substrate for 
organising dissociated cells into an appropriate tissue construct in vitro or in vivo [18].  
Hepatocytes are anchorage-dependent cells with heavy metabolism functions.  Based 
on this feature, the first scaffold material requirement for hepatocyte substrates is 
adequate strength and good cell adhesive property.  This is to ensure prolonged periods 
of survival, reorganization, proliferation, and function for the hepatocytes.  The second 
requirement is a microporous structure for diffusion of oxygen or nutrients and 
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removal of waste from the implanted cells, as well as providing space for neo-
visualisation from the surrounding tissue [13]. 
Generally, materials used in liver tissue engineering are categorised as natural, 
synthetic or hybrid polymers.  In this chapter, only those that are relevant to this study 
are briefly discussed as follows. 
n Natural polymers 
Various natural polymers such as collagen, alginic acid, and chitosan have been 
used for liver tissue engineering due to their good biocompatibility [19-23].  However, 
they are not idea 3D scaffolds materials due to their poor stability and mechanical 
properties.  Among the natural polymers, collagen was selectively adopted in this 
study to fabricate our biomimetic and bioactive scaffolds because one major 
extracelluar matrix component of human liver is collagen. 
Collagen is synthesised by a variety of cells such as hepatocytes, HSCs and 
endothelial cells.  In tissue engineering, collagen is applied in two major approaches.  
First, purified collagen can be solubilised or dispersed, and subsequently reconstituted 
in a pre-designed form or shape, with or without further crosslinking.  Alternatively, 
biological structures like umbilical veins, tendons or heart valves are intact to remove 
non-collagenous components, so that the remaining intact collagen material can be 
crosslinked before implantation.  In terms of the chemical structure of collagen, the 
polypeptide strands of collagen consist of repeating tri-peptide of Gly-X-Y, where 
proline is mainly found in the X-position and hydroxyproline in the Y-position [3]. 
To form crosslinked, reconstituted collagen scaffolds as cell substrates in tissue 
engineering, two methods are generally used: the physical or chemical method. 
 Chapter 2  Literature Review
 
 Page 2-13 
 
Physical method.  This method includes the use of dry heat or exposure to UV to 
avoid introducing potential cytotoxic chemical residues to the collagen scaffold [24].  
However, collagen becomes partially denatured after these physical treatments.  
Nevertheless, formation of crosslinks by UV irradiation only indicates a lower degree 
of crosslinking [21]. 
Chemical method.  With this method, reagents like glutaraldehyde (GA) and 
formaldehyde introduce crosslinks between two amino groups of lysine or 
hydroxylysine residues.  This method improves the biological stability of the 
crosslinked collagen scaffolds as well as suppressing the immunogenicity of implanted 
constructs.  However, both regents were incorporated with collagen, which resulted in 
the potential cytotoxicity of the crosslinked collagen scaffold [25].  Therefore, several 
alternative crosslinking agents have been sought in order to replace them.  Amongst 
which are N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) and 
N-hydroxysuccinimide (NHS).  The reaction of EDC with carboxylic acid groups of 
collagen results in the formation of O-acylisourea.  When O-acylisourea reacts with 
NHS, reactive NHS-esters are generated and water-soluble 1-ethyl-3-(3-aminopropyl) 
urea (EDU) is released.  Subsequently, reaction of NHS-esters with free amino groups 
of (hydroxy) lysine residues results in the formation of peptide crosslinks and releases 
NHS.  EDC/NHS-crosslinked collagen is reported to be non-cytotoxic in vitro [26]. 
o Synthetic polymers 
Synthetic polymers offer several advantages over natural materials.  They can be 
prepared with controlled chemical and physical properties and can be made available 
in almost unlimited quantities [25, 27].  Degradation rate and mechanical properties of 
synthetic polymers can be altered by simple chemical modification.  This results in 
scaffolds with degradation times ranging from several days up to numerous years.  In 
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terms of mechanical properties, these scaffolds are suitable for applications such as 
skin, cartilage and bone replacement [28-30].  However, the feasibility of applications 
in tissue engineering is limited due to their poor biocompatibility.  In the present study, 
two types of common synthetic biodegradable polymers were used: (1) Poly(lactic-co-
glycolic acid) (PLGA) which is the copolymer of poly(glycolic acid) (PGA) and 
poly(lactic acid) (PLA); and (2) Polycaprolactone (PCL). 
PGA is a semi-crystalline, biodegradable polymer with a melting point (Tm) of 
about 225°C and a glass transition temperature (Tg) of about 35−40°C.  The 
degradation of PGA is performed by hydrolysis of aliphatic-ester linkages.  In general, 
the degradation time of PGA is a few weeks depending on its molecular weight, degree 
of crystallinity, crystal morphology, physical geometry and its environment.  PLA, a 
biodegradable polymer, exists in two stereo forms, namely poly(L-lactic acid) (PLLA) 
and poly(D,L-lactic acid) (PDLLA).  The former is semi-crystalline with a Tm of 
173−178°C and a Tg of about 65°C.  The latter is a completely amorphous polymer 
with a Tg of about 57°C.  The methyl group in PLA causes the ester linkage to be less 
accessible to hydrolytic attack as compared with PGA.  This results in a slower 
degradation rate than that of PGA [31].  PLGA is the copolymer of PGA, and PLA is 
also a commonly used biodegradable polymer.  The speed of degradation of PLGA 
could be easily controlled through the ratio of PGA and PLA in the copolymer [25]. 
PCL is a semi-crystalline, biodegradable polymer with a Tm of about 60°C and a Tg 
of about −60°C.  The presence of the hydrolytically unstable aliphatic-ester linkage 
causes the polymer to be biodegradable.  However, less of ester linkages in the 
polymer main chain results in its slow degradation as compared to PLA, PGA and their 
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PLGA copolymer.  Furthermore, oxygen atoms in the polymer main chain result in its 
excellent elongation and process ability [32]. 
p Hybrid polymers 
The rationale of a hybrid material is to combine respective advantages and 
overcome the shortcomings of the aforementioned two types of polymers.  With 
synthetic polymers, their advantages lay in their excellent shaping/process ability, 
good mechanical properties, adjustable degradation rate and low production costs.  
However, their lack of specific domains results in poor cell affinity[33].  On the 
contrary, natural polymers such as collagen inherent in biological ECM — have the 
merit of specific cell interaction domains.  Consequently, biological signals can be sent 
to guide cells at various stages of development through the interactions.  For example, 
the arginine-glycine-aspartate (RGD) domain has been shown to represent the minimal 
adhesion domain to stimulate cell adhesion [34]. However, as they are isolated from 
human or animal tissues, they are typically not available in large quantities and suffer 
from batch-to-batch variations.  In addition, they are not as malleable as the synthetic 
polymers, and their mechanical strength is also typically poor.  Very clearly then, these 
two types of polymers are mutually complementary in terms of their respective 
attributes. 
Against this background, Chen et al. [35] developed a hybrid scaffold by 
introducing natural polymer (collagen) microsponges into the pores of a synthetic 
polymer (PLGA (75:25)) sponge.  Firstly, the porous PLGA sponge was fabricated by 
using a solvent casting-particulate leaching technique, and then infiltrated with 
collagen solution.  After freeze-drying, the hybrid scaffold was further crosslinked 
with GA vapour.  Mouse fibroblast L929 cells were seeded in this hybrid scaffold and 
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cultured for 5 days.  Fibroblast cells adhered and proliferated well in this scaffold, 
thereby suggesting good biocompatibility of this hybrid scaffold. 
Similarly, Hokugo et al. [36] developed a new scaffold consisting of fibrin and 
PGA fibres.  In their work, PGA fibres were homogeneously blended in a mixture of 
fibrinogen and thrombin solution, and then freeze-dried to form a fibrous fibrin-PGA 
scaffold.  From mechanical testing, it was found the mechanical strength of this hybrid 
scaffold was significantly enhanced, as the compression modulus of this hybrid 
scaffold was significantly higher than that of fibrin scaffold alone.  Based on fibroblast 
seeding and culture in vitro, or scaffold culture under mouse skin in vivo, the improved 
biocompatibility of hybrid scaffold was revealed in terms of cell attachment and cell 
ingrowths. 
In summary, a hybrid material is advantageous over either of its constituents alone.  
However, compatibility between the constituents is a potential issue to consider and 
contend with because it affects the mechanical properties and cell affinity of the hybrid 
scaffold.  In both works cited above, the natural polymer was just physically connected 
with the synthetic polymer.  This may result in the dissociation of the hybrid scaffold 
with a longer culture period.  Proper compatibility may be obtained by establishing 
strong covalent interactions that between the two types of polymers. 
2.2.2.2 Scaffold fabrication  
In this section, four different techniques of fabricating scaffolds are briefly 
reviewed and discussed: textile, solvent casting-particulate leaching, freeze-drying and 
CAD/CAM. 
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n Textile technique 
Textile technique which is used to form fibrous scaffolds has been widely applied 
in tissue engineering.  This is because fibres provide a large surface area-to-volume 
ratio and are therefore desirable as a scaffold matrix material.  Non-woven scaffolds 
are typically fabricated by fusing small fibres together into the form required, and then 
binding them mechanically (with an adhesive).  However, non-woven scaffolds lack 
structural stability to withstand biomechanical loading.  Hence, a number of studies 
were carried on with a view to offering fibrous scaffolds with better mechanical 
properties. 
Against this background, Mikos et al. [37] developed a technique to improve the 
mechanical properties of non-woven structures.  Non-woven PGA fibres were coated 
with PLLA solution in methylene chloride, which was a solvent for PLLA but not 
PGA.  After methylene chloride evaporated completely, the PLLA-PGA composite 
was heated above PGA melting temperature at 195°C and PLLA was selectively 
removed later.  By using this technique, PGA fibres were welded together to form a 
stable fibrous PGA structure.  However, the application of this technology in tissue 
engineering was restricted by the chemical solvent used and difficult control of the 
macroscopic shape, porosity and pore size. 
Another type of textile technique to improve the mechanical properties of fibrous 
scaffolds is knitting or braiding technique [38, 39].  In knitting technology, a yarn is 
used for coherent assembly of fibres to form a stable fabric structure via interlocking 
fibres.  The mechanical behaviour of a knitted fabric shows progressive stiffening with 
increasing deformation.  The drawback of this technique is the two-dimensional 
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structure of the product, and thus the accompanying anisotropy in terms of mechanical 
property and geometry. 
o Solvent casting-particulate leaching technique 
This technique was developed to prepare porous structures with regular porosity, 
but with limited thickness [40, 41].  First, the selected polymer is dissolved in an 
organic solvent with porogen particles, and then the mixture is cast into a mould.  The 
porosity and pore size distribution in scaffolds depend on the amount and size of 
porogen particles.  After the solvent evaporates completely, the composite structure is 
immersed into a bath with solvent for the porogen particles.  In this manner, the 
particles dissolved and leached out to form a porous structure. 
This technique is characterised by its simple operation and adequate control of pore 
size and porosity.  However, the particles cannot be easily washed out with water.  
Therefore, most of the porous materials prepared by particulate leaching method are 
limited to two-dimensional films.  Scaffolds with thick sections cannot be made as 
deeply embedded porogens become too distant from the surface and residual porogens 
may be left in the final structure.  Apart from limited scaffold thickness, another 
drawback of this technique lies in its use of chemical solvents.  The latter must be fully 
removed to avoid any residual solvents in scaffolds that may be harmful to the cells 
seeded in the scaffold. 
p Freeze-drying technique 
This technique does not require the use of a solid porogen.  First, a synthetic 
polymer is dissolved in a suitable solvent.  Water is then added to the polymer solution, 
and the two liquids are mixed to obtain an emulsion.  Before the two phases can 
separate, the emulsion is cast into a mould and quickly frozen by means of immersion 
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into liquid nitrogen.  The frozen emulsion is subsequently freeze-dried to remove the 
dispersed water and solvent, thus leaving a solidified, porous polymeric structure [42]. 
The emulsification and freeze-drying method allows a faster preparation when 
compared to solvent casting-particulate leaching.  This is because it does not require a 
time-consuming leaching step.  However, it still requires the use of solvents.  
Moreover, pore size is relatively small and porosity is often irregular. 
Freeze-drying by itself is also commonly employed for the fabrication of scaffolds.  
In particular, it is used to prepare collagen scaffolds (sponges) [43].  Collagen is 
dissolved in an acidic solution first.  Subsequently, the collagen solution is cast into a 
mould and frozen with liquid nitrogen.  Finally, it is lyophilised to form scaffolds of 
desired shapes. 
q CAD/CAM technique 
To effective control porosity and pore size, computer assisted design (CAD) and 
manufacturing (CAM) techniques have been introduced to tissue engineering.  A three-
dimensional structure is designed by CAD software, and then the scaffold is realised 
by using either inkjet printing or fused deposition modelling [44]. 
Inkjet printing is a process for solid freeform fabrication.  It produces components 
by inkjet-printing a binder into sequentially deposited layers of powder.  This process 
— incorporating powder and binder, layer by layer — repeats until the 3D scaffold is 
completed.  Giordano et al. [45] studied the mechanical properties of inkjet printed 
PLLA parts.  Scaffolds were fabricated by PLLA powders (low or high molecular 
weight) with chloroform as a binder.  The maximum measured tensile strength for the 
low-molecular-weight PLLA (53,000) 3D scaffold was 17.40±0.71 MPa, while that of 
high-molecular-weight PLLA (312,000) was 15.94±1.50 MPa. 
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Like inkjet printing, fused deposition modelling (FDM) is another technique to 
form structure-defined 3D scaffolds [46, 47].  However, the connection of layer to 
layer in FDM is based on the polymer melting-solidification process, but not by the 
binder.  In this technique, thermoplastic polymer filament is fed into a temperature-
controlled FDM extruder, where it is heated to a semi-liquid state.  The head extrudes 
and deposits semi-liquid fibre on a fixture-free base.  According to CAD design, the 
head directs the fibre precisely into place to solidify and be laminated to the preceding 
layer.  After a layer is completed, the height of the extrusion head is increased and the 
subsequent layers are built until the 3D scaffold is completed. 
In this present study, PCL scaffolds were fabricated by FDM.  Our results indicated 
a fully interconnected, porous network structure in a 3D scaffold.  Due to the 
computer-controlled processing, the scaffold fabrication process was highly 
reproducible. 
2.2.2.3 Scaffold surface modification 
Presently, porous 3D polymeric scaffolds are widely considered in many 
biomedical applications, including as implanted substrates in tissue regeneration for 
cell attachment, proliferation and differentiation [30, 48, 49].  Alternatively, they are 
also being considered for drug delivery systems for more accurate distribution and 
timing of drug administration [50].  However, most polymeric scaffold surfaces lack 
specific domains for cells or drugs to form well controllable specific interactions [51].  
This shortcoming hinders their applicability as ideal cells substrates or drug carriers 
[52, 53]. 
To overcome this critical shortcoming, surface chemistry has been utilised to 
control the interactions between the surface of scaffold and cells or drugs.  Surface 
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modification is a widely adopted strategy as it affords the prominent advantage of 
changing the surface properties of polymeric materials, while keeping the bulk 
properties intact [54-57].  Amongst the plethora of surface modification methods, 
surface deposition emerges as the commonly used method.  This is because drugs or 
cell-specific interaction domains of a desired high density can be directly and easily 
deposited on the polymeric scaffold surface through physical adsorption.  However, 
this method renders poor stability [58]. 
Alternatively, surface grafting is another means whereby a desired high density of 
drugs or cell-specific interaction domains can be immobilised on the polymeric 
scaffold surface with covalent bonding.  Unlike surface deposition, this method renders 
good stability [33, 58, 59].  In surface grafting, active free radicals are first generated 
on the polymeric scaffold surface.  Next, either specific polymers which possess 
functional groups are grafted on the polymeric scaffold surface through free radical 
polymerisation, or that drugs and specific domains are covalently bonded directly on 
the polymeric scaffold surface [60-62].  To date, several surface grafting modification 
techniques have been developed to generate free radicals, such as plasma discharge, 
UV irradiation; electron beam irradiation, ozone treatment and chemical modification. 
Park et al. [63] demonstrated collagen grafting on the surface of polyurethane (PU) 
films via ozone treatment, and then fibroblast attachment and proliferation on these 
surface-modified films were evaluated.  After ozone-induced oxidation of these PU 
films, peroxide groups were generated on the surface.  Then, these peroxides were 
broken by redox-polymerisation, thereby further providing active species to initiate 
collagen immobilisation by reacting with amines in the collagen molecules.  XPS 
indicated that the PU film surface was effectively grafted with collagen.  Fibroblast 
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culture experiment also indicated enhanced fibroblast attachment and proliferation on 
collagen-grafted PU films due to good biocompatibility of collagen. 
Ito et al. [64] reported that proteins such as insulin, fibronectin and poly-lysine 
were covalently coupled on the surface of poly(ethylene terephthalate) (PET) films.  
Carboxyl groups were generated on the surface of PET films via hydrolysis of PET 
films in NaOH solution.  Then, proteins were immobilised by forming covalent bonds 
on PET films with water-soluble carbodiimide (WSC).  The results demonstrated that 
cell adhesion was remarkably enhanced by fibronectin and poly-lysine immobilisation 
on one hand, and cell growth was accelerated by insulin immobilisation on the surface 
of PET films on the other hand.  Specific biocompatibility of PET film was also 
achieved though this surface modification method. 
Wan et al. [65] modified the surface of silica-incorporated polyelectrolyte-complex 
fibers with collagen.  Cell attachment and proliferation of human hepatocellular 
carcinoma cells (HepG2) cultured on it were then evaluated.  By means of phase 
contrast microscopy, it was shown that the surface-modified fibres were highly 
amenable towards cell attachment and proliferation.  However, cells either proliferated 
poorly or formed clumps on the surface of silica-incorporated fibres. 
Cheng et al. [33] modified an ultra-thin PCL surface with collagen immobilisation 
by plasma induction and UV-initiated polymerisation in our laboratory.  The PCL film 
was pre-treated with argon plasma, and then UV-polymerised with acrylic acid (AAc).  
Collagen immobilisation was then carried out.  The surface of modified film was 
characterised by X-ray photoelectron spectroscopy, atomic force microscopy, water 
contact angles and cell culture experiments.  Results showed that collagen molecules 
were successfully immobilised on the surface of PCL film, and the 
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hydrophilicity/roughness of the surface improved significantly after surface 
modification.  As for the effect on cell attachment, it was shown that the cell 
attachment and proliferation of human dermal fibroblasts and myoblasts were 
remarkably improved on the modified surface too. 
By means of electron beam (EB)-induced graft polymerisation of acrylic acid, Sun 
et al. [66] immobilised RGD onto nano-patterned polycaprolactone with parallel 
grooves.  After free radical induction by EB irradiation, a high concentration of 
carboxylic groups was introduced onto the polymer substrate by free radical 
polymerisation of acrylic acid.  For coupling of the RGD peptide on the carboxylated 
polymer surface, the surface was activated by EDC and NHS.  The final 
immobilisation of the peptide was via a thioldisulfide exchange reaction.  A 
preliminary in vitro study of the behaviour of keratinocytes (NCTC 2544) showed that 
most cells had a spread, rounded appearance on the coupled surface.  On the other 
hand, the majority of cells were elongated along the grooves on uncoupled substrates. 
Yang et al. [67] reported the surface modification of a PLA film with collagen.  It 
was carried out by one step polymerisation via gamma irradiation with AAc as a 
coupling agent.  The immuno-staining results showed high levels of collagen on the 
grafted PLLA.  The presence of collagen epitopes (i.e., reactivity of the antibody 
against collagen) on the surface of grafted PLLA demonstrated that irradiation may 
alter the molecular weight of collagen, but not the availability of active binding sites.  
These results thus indicated that the single-step procedure of grafting by gamma 
irradiation could provide a simple but efficient technique to modify the 
biocompatibility of a scaffold.  However, the single-step procedure could result in 
homopolymerisation of AAc associated with collagen grafting. 
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Currently, most of the successfully surface-modified porous polymeric scaffolds 
are restricted to two-dimensional membranes.  In other words, uniform surface 
modification of 3D porous scaffolds, especial bulky scaffolds, remains a challenge [68]. 
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2.2.3 Tissue culture  
2.2.3.1 Coculture  
In tissue engineering, coculture technique is developed with a view to modulating 
cell functions by physically or chemically manipulating cell-cell interactions [69].  
Coculturing of hepatocytes with a range of different cell types has been studied 
extensively [7, 70, 71].  The aim is to improve the phenotypic stability of hepatocytes 
by mimicking the in vivo microenvironment of hepatocytes.  Cells used in such studies 
include fibroblasts, whole non-parenchymal cell fractions, stellate cells, liver epithelial 
cells, bone marrow cells and liver sinusoidal endothelial cells. 
Bhandari et al. [72] reported on a coculture of fixed 3T3 fibroblasts with rat 
hepatocytes in 24-well tissue culture plate under a static culture condition for 20 days.  
The results indicated that hepatocytes under coculture maintained viability with well-
formed canalicular systems.  Two hepatic functions, albumin secretion and EROD 
activity, were displayed too.  In contrast, hepatocytes under monoculture declined 
quickly in viability and lost two hepatic functions.  It should also be mentioned that 
this study demonstrated that the fibroblast-conditioned medium of 3T3 fibroblast was 
not responsible in preserving hepatocyte viability and functionality. 
Zinchenko et al. [73] experimented with coculturing Kupffer cells with hepatocytes 
on micropatterned surfaces.  The objective was to understand the effect of heterotypic 
interaction between these two cell types on the differentiate function of hepatocytes.  
The results indicated that coculturing hepatocytes with Kupffer cells at different cell 
ratios will alter the hepatic functions expressed by hepatocytes in terms of albumin 
secretion and urea production. 
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Uyama and Higashiyama [74, 75] reported on coculturing hepatocytes with active 
hepatic stellate cells under mixed coculture or separate coculture in tissue culture plate.  
The results indicated that hepatocytes under mixed coculture exhibited lower level of 
albumin secretion than that under monoculture control.  In contrast, hepatocytes under 
separate coculture maintained the activity levels of albumin secretion and urea 
production. 
In summary, the abovementioned studies suggested that coculturing hepatocytes 
with non-parenchymal cells influenced the differentiation function expressed by 
hepatocytes.  This was probably due to the favourable cell-cell interaction between 
them. 
2.2.3.2 Bioreactor  
Bioreactor technique is an important tool in tissue engineering because of these 
twofold benefits: (1) improves mass transfer in 3D scaffolds; and (2) provides physical 
stimuli to influence tissue development.  Due to the bioreactor application, large-sized, 
well-organised and functional engineered tissues constructs have become feasible.  
These engineered tissue constructs include, but are not limited to, skin, cartilage, bone, 
heart, and liver tissues [76-79].  In liver tissue engineering, the most profound 
bioreactor applications are in the development of BAL devices or growth of 
implantable, tissue-engineered constructs in vitro. 
A BAL device aims to be a “bridging” strategy for ALF patients until the patient’s 
own liver recovers, or that a compatible liver is available for liver transplantation 
under a stable neurological status [80-82].  Therefore, BALs should provide ALF 
patients with the protein synthesis, regulatory and detoxification functions which are 
forfeited by liver failure and which are essential for stopping progression of liver cell 
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damage or promoting regeneration of liver parenchyma.  To fulfil the intended roles of 
BAL devices, the bioreactor should possess these capabilities: (1) cultivate cells at a 
high density, amounting to about one-third of natural liver cell mass; (2) high 
maintenance of function for a period ranging from a few days to a few weeks; (3) low 
priming volume, as limited by volume of human donor blood, for extracorporeal 
circulation [14, 83]. 
The BAL device strategy was initiated in 1956 by Sorrentino, who homogenised 
fresh liver and evaluated the detoxification and urea production functions of this 
homogenate.  In the early stage of BAL device development, liver cells were cultured 
between hollow fibres in a shell-and-tube type bioreactor in one of the following forms: 
as suspension cell clumps, attached to microcarriers, or directly adherent on the outer 
surface of hollow fibres (as shown in Figure 2.5). 
 
Figure 2.5  Scheme of early stage BAL devices: (a) hepatocytes attached on the outer surface of 
hollow fibres; (b) hepatocytes suspended between hollow fibres; or (c) hepatocytes 
bound to microcarriers [14] 
There are several advantages with this design: (1) relatively large surface area-to-
volume ratio with improved mass transfer of nutrient, oxygen and metabolites; (2) 
immunoisolation function of hollow fibre membrane; (3) prevented cell damage by 
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shear stress through membrane barrier.  However, mass transfer of nutrients, oxygen 
and metabolite waste products were still poor with regard to the requirement of live 
cells cultured in BAL devices.  This shortcoming thus led to low cell viability.  
Moreover, lack of specific substrate-cell stimuli resulted in less cell adhesion on the 
surface of hollow fibres in one hand and low functionality of live cells on the other 
hand. 
In the 1990s, several new-generation BAL devices were developed, as shown in 
Figure 2.6.  A key change introduced in these new devices was the control of oxygen 
delivery or cell-substrate interaction.  Nyberg et al. [84] developed the Algenix 
(LIVERx2000), in which primary porcine hepatocytes harvested from pigs are 
suspended in a cold collagen solution and are injected inside the hollow fibres, while a 
warm medium is perfused outside the fibres.  After collagen gelation, the liver cells’ 
pull on the collagen gel causes the latter to contract to 60% of its original diameter.  
Within the resulting space, a nutrient-rich medium stream is perfused for normal 
functioning of the liver cells.  At the same time, the patient’s blood circulates outside 
the hollow fibres.  An additional advantage of this BAL device is that hepatocytes are 
cultured with cell-substrate interaction, mimicking the environment in vivo.  However, 
the presence of collagen gel increased the resistance to mass transfer of nutrients, 
oxygen and metabolite waste products in the BAL device. 
Gerlach et al. [83] developed the Modular Extracorporeal Liver System 
(MELS), which is composed of the following modules: (1) Cell module, in where 
hepatocytes are cultured (hollow fibre reactor); (2) Detoxification module, where an 
albumin-impregnated dialyser removes albumin-bound toxins; and (3) Dialysis module, 
which contains a kidney dialyser.  The cell module comprises three bundles, each of 
which is made up of many hollow fibres as shown in Figure 2.7.  When one of the 
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three bundles supplies oxygen and eliminates excess carbon dioxide, the other two 
serve as inflow membrane and outflow membrane for mass exchange.  Human 
hepatocytes are cultured between the hollow fibres as cell aggregates.  The key 
advantage of MELS lies in is its highly efficient mass transfer of nutrients, oxygen and 
metabolite waste products.  However, its operation is too complex. 
(A) 
(B) 
Figure 2.6 Schemes of BAL devices: (A) Algenix (LIVERx2000); and (B) MELS cell module [14] 
Flendrig et al. [85] developed the AMC-BAL system, as show in Figure 2.7.  It is 
composed of a dialysis housing comprising a three-dimensional non-woven fabric for 
high-density hepatocyte culture as small aggregates, and hollow fibre membranes for 
oxygen supply and CO2 removal.  A region is created by combining the matrix sheet 
and oxygenation hollow fibres, through which the patient blood or plasma is perfused 
and the latter being in direct contact with the hepatocytes in the fabric.  The 
homogenous distribution of the oxygenation fibres throughout the bioreactor 
compartment ensures that every hepatocyte has an oxygenation source within its direct 
surroundings.  The prominent advantage of this system is the optimal oxygenation of 
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the liver cell due to oxygenation fibres inside the bioreactor.  There is no semi-
permeable barrier between the patient plasma and the liver cell aggregates, hence 
simulating liver cell perfusion conditions in vivo.  Moreover, this system enables 
relatively high cell attachment and the possibility of specific cell-substrate interaction 
as a result of appropriate surface modifications. 
 
Figure 2.7  Scheme  and details of AMC-BAL (http://www.xs4all.nl/~reitsma/wwwarticle1.html) 
Despite the many advantages of the abovementioned BAL devices, they do have 
some limitations.  The major deficiency is limited mass transfer due to adsorption of 
protein in plasma/culture medium onto the surface of hollow fibres (i.e., fouling), 
which becomes worse as culture time increases [11].  One solution to the fouling 
problem is to change the flow configuration, but shear stress generated on the cell 
membrane will influence hepatocyte viability in the BAL device [86].  The second 
deficiency is the inability to maintain a mass of hepatocytes due to the low surface-to-
volume ratio of hollow fibres [87], thereby resulting in low cell seeding capacity.  It 
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should be highlighted that at least 1010 hepatocytes must be packed in a BAL device in 
order to support a patient’s failing liver [11]. 
Another application of bioreactor in liver tissue engineering is growth of liver 
tissue-engineered constructs in vitro.  This application aims at treatment of ALF or 
CLF by replacing disease livers via implantation of degradable tissue constructs that 
contain functional liver cells, and subsequently integration in vivo [14].  The chief role 
of a tissue construct is to guide the restoration of structure and function of diseased 
liver, and ultimately degrades and resorbs into human body after the cells produce their 
own ECM.  In this connection, the bioreactor can be used to provide appropriate 
biochemical and mechanical cues that promote the organisation of different liver cell 
types and differentiation of liver stem cells in the tissue construct.  To date, only a few 
bioreactors have been proposed for this purpose and only rather small liver cell-seeded 
constructs were used. 
Kim et al. [88] proposed culturing rat hepatocytes in micro-porous PLGA 
cylindrical tissue constructs.  These constructs were fabricated by solvent casting-
particulate leaching technique through Cellmax Quad flow perfusion bioreactor.  
Dynamic cell seeding permitted cells to distribute uniformly throughout the scaffold.  
A better oxygenated cell culture status was observed versus that of static culture, and a 
stable albumin production was yielded after 2-day cell perfusion culture. 
Fiegel et al. [56] studied the influence of flow perfusion and matrix coating on 
differentiation functions of rat hepatocytes in a Minicells flow chamber.  Rat 
hepatocytes were seeded in ECM-coated PLGA porous scaffolds (which were 
fabricated by gas foaming-particulate leaching technique) and perfusion-cultured for 
10 days.  The results indicated that perfusion exerted a stimulatory effect on cell 
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attachment and function maintenance.  Besides, ECM coating increased the cell 
numbers in scaffolds and allowed stable cell function over a 10-day culture. 
Kataoka et al. [87] reported that human hepatocellular carcinoma cells (HepG2) 
were perfusion-cultured in porous polydimethylsiloxane (PDMS)-TEO scaffolds 
fabricated by particulate leaching technique in a radial flow bioreactor for 3 days.  The 
results showed that cells proliferated actively and formed cell clusters more efficiently 
than in a polyvinyl-alcohol scaffold.  Furthermore, albumin production in this reactor 
was three-fold greater than that secreted in a monolayer culture due to a 3D culture. 
Despite the many advantages of the abovementioned liver tissue constructs in 
bioreactor, there are some limitations associated with them.  Currently, most 
bioreactors are direct perfusion bioreactors that have been utilised to culture 
hepatocytes.  Although the overall survival rate of tissue constructs is improved 
compared to those in conventional static culture, there exists gradients of functionality 
and mechanical properties from the surface of the construct to the inner core of the 
construct.  This is because only the surface of the construct experiences fluid flow and 
mechanical conditioning[89]. 
2.2.4 Summary 
The development of BAL devices or cell-based transplantation therapies is still in 
“infancy to adolescence” stage after 50 years of progress.  This is largely because the 
most significant challenge of successfully maintaining a mass of viable and functional 
hepatocytes outside of native liver environment has not been overcome. 
In this chapter, a review on the various means to overcome the noted challenges in 
liver tissue engineering has been presented. The major means are material 
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hybridisation with surface modification, coculture and perfusion culture.  Material 
hybridisation with surface modification provided a strategy to form 3D fibrous 
scaffolds with bioactive surface and appropriate mechanical strength for cell 
reorganisation.  Coculture modulated cell functions by physically or chemically 
manipulating cell-cell interactions.  Perfusion culture improved mass transfer of 
nutrients, oxygen and waste products around cells in 3D scaffolds, which makes high-
density cell packing feasible in BAL devices.  Consequently, these means with further 
developments have been selected for scaffold fabrication and tissue construct culturing 
in the present study. 
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3.1 INTRODUCTION 
Biodegradable polymer scaffolds have been widely used to provide temporary 
support for cellular survival in tissue engineering [1].  However, an ideal scaffold for 
tissue engineering applications must not only demonstrate adequate strength and 
possess a porous structure to facilitate diffusion of oxygen, nutrients and waste 
products to and from the cells, it must also exhibit good cell attachment properties to 
sustain cell proliferation and functions [2−4]. 
Arginine-glycine-aspartate (RGD) has been shown to represent the minimal 
adhesion domain required to stimulate cell attachment [5].  Collagen, on the other hand, 
a natural, RGD-rich polymer, is one of the important extracellular matrix (ECM) 
components [6].  As such, it is being considered intensively in many biomedical 
applications as an implanted substrate in tissue regeneration for cell attachment, 
proliferation and differentiation using a 3D organisation — as that which would occur 
in vivo [7−10].  Furthermore, the fabrication of collagen substrates is buttressed by 
well-established technologies, in particular freeze-drying without the use of toxic 
chemicals and extreme heating [11]. However, the mechanical strength of collagen 
substrates is poor (compression modulus 0.01-0.03 MPa), especially when pitted 
against synthetic polymer scaffolds — a well-liked choice whenever substrate 
materials are considered.  On this note, poly(lactic-co-glycolic acid) (PLGA) is a 
biodegradable synthetic polymer which has many advantages such as: acceptable 
mechanical strength(compression modulus 2-7 GPa) [8,12−14], well controlled 
degradation rate, and easily fabricated into the desired shapes [15,16].  However, most 
of the scaffold fabrication technologies for PLGA substrates entail the use of toxic 
chemicals and extreme heating.  Furthermore, cell attachment on PLGA is relatively 
poor when compared with natural ECMs such as collagen [9,17]. 
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Putting together the pros and cons of both collagen and PLGA, it is thus logical to 
propose a hybrid PLGA-collagen scaffold to harness their individual strengths.  In 
other words, the hybrid PLGA-collagen scaffold would possess the advantages of a 
fibre-based scaffold without the disadvantages of using toxic chemicals and extreme 
heating associated with synthetic polymer scaffold fabrication.  To date, reports have 
been published by other researchers on the fabrication of PLGA-collagen sponges [8,9].  
However, the collagen in their scaffolds is physically adsorbed onto the PLGA surface 
and which is easily detached under cell culture conditions [18].  Against this 
background, the objectives of this study were: 
(1) To develop a means to graft collagen onto the surface of PLGA fibres through 
surface modification; 
(2) To form a hybrid 3D PLGA-collagen scaffold by embedding collagen-grafted 
PLGA fibres in collagen sponges; and 
(3) To evaluate the feasibility of using this hybrid PLGA-collagen scaffold for 
surrogate tissue application in vitro. 
In view of the above objectives (1) to (3), the surface of hydrolysed PLGA fibres 
was grafted with collagen by N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) 
in combination with N-hydroxysuccinimide (NHS) [10,19].  Thereafter, these 
unstructured, collagen-modified PLGA fibres were randomly blended in collagen 
sponges to form a fibrous scaffold by freeze-drying.  To further stabilise this construct, 
collagen in the scaffold was crosslinked.  Then, to evaluate the feasibility of this 
scaffold as a cell substrate for liver tissue engineering, cell attachment and metabolism 
activity of cells in this scaffold were examined. 
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3.2 EXPERIMENTAL DETAILS 
3.2.1 Materials 
PLGA sutures with a lactic acid to glycolic acid ratio of 10:90 were purchased 
from Ethicon (Johnson & Johnson, Singapore). N-hydroxysuccinimide (NHS) was 
supplied by Pierce (Research Instruments, Singapore).  The 2-(N-morpholino)-
ethanesulfonic acid in aqueous solution (0.1 M MES), N-(3-dimethylaminopropyl)-N'-
ethylcarbodiimide hydrochloride (EDC), and epidermal growth factor (EGF) were 
obtained from Sigma−Aldrich Pte Ltd (Singapore).  Dulbecco’s modified Eagle 
medium (DMEM), Williams’ E medium and insulin were purchased from Invitrogen 
Singapore Pte Ltd.  Vitrogen collagen solution (3 mg/ml) dissolved in 0.012 N HCl 
was purchased from Cohesion Technologies Inc. (USA).  BD™ 3D Collagen 
Composite Scaffolds were purchased from Becton Dickinson (Singapore). 
3.2.2 Scaffold preparation 
3.2.2.1 Surface modification of PLGA fibres 
Figure 3.1 is a schematic illustration of the surface modification process of PLGA 
fibres.  The entire process comprised the bellow steps: 
Hydrolysis of PLGA fibres: PLGA sutures were cut into lengths of 1 cm and then 
loosened with tweezers to obtain free, unstructured PLGA fibres.  Those PLGA fibres 
were immersed in ethanol for 1 h to remove impurities, and then rinsed in deionised 
water for 30 min.  After drying with a vacuum desiccator, the fibres were immersed in  
0.1 M sodium hydroxide (NaOH) solution for 30 min at 20°C.  Hydrolysed fibres were 
then washed three times with deionised water at 20°C for 30 min each. 
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Grafting of collagen on surface of PLGA fibres: Hydrolysed fibres were 
immersed in 100 mL of 10 mM MES buffer with 40 mM EDC and 10 mM NHS at pH 
6 at 4°C overnight to activate the carboxyl (−COOH) groups on the surface of PLGA 
fibres.  Activated fibres were then incubated in collagen type I-phosphate buffered 
saline (PBS) solution at a concentration of 0.3 mg/mL for 5 h at 4°C for collagen 
grafting.  Finally, the grafted PLGA fibres were washed with copious amounts of PBS 
(pH 7.4) to remove weakly bound collagen.  PLGA fibres grafted with collagen were 
freeze-dried and kept in a desiccator. 
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Figure 3.1 Schematic drawing for surface modification of PLGA fibres 
3.2.2.2 Fabrication of hybrid PLGA-collagen scaffold 
Hybrid PLGA-collagen fibrous scaffold was fabricated by first lyophilising 
surface-modified PLGA fibres blended with collagen solution, followed by collagen 
crosslinking using EDC and NHS.  Briefly, 20 mg of surface-modified PLGA fibres 
was homogeneously placed into a stainless steel mould and 0.5 mL of collagen 
solution was poured into each mould.  The mould with PLGA fibres and collagen 
solution was frozen at –80°C and lyophilised to obtain a hybrid scaffold consisting of 
collagen sponges reinforced by PLGA fibres. 
Lyophilised scaffolds were incubated in 10 mM MES buffer for 30 min, followed 
by immersion in a solution of 40 mM EDC and 10 mM NHS in 10 mM MES buffer.  
Crosslinking of collagen was carried out under a gentle shaking condition at 4°C, and 
which stopped after 2 h.  After repeated washing with deionised water (3 times for 30 
min each), the scaffolds were dried and stored in a desiccator. Before the scaffolds 
were  used for cell seeding, the scaffolds were sterilised by exposure to a 60Co source 
until a total dose of 25 KGy was achieved [16,19]. 
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3.2.3 Scaffold characterisation 
3.2.3.1 Scanning electron microscopy (SEM) 
PLGA fibres and cross-sections of hybrid PLGA-collagen scaffolds were observed 
with a JSM-7400M field emission scanning electron microscope.  The PLGA-collagen 
scaffolds were cut into blocks of 2 mm thickness with a razor blade.  Then, PLGA 
fibres and cross-sections of scaffolds were gold coated by ion sputtering with a Jeol 
JFC-1200 fine coater at 30 mA for 80 seconds before being viewed by SEM . 
 
3.2.3.2 X-ray photoelectron spectroscopy (XPS) measurement 
XPS measurements were carried out as described previously [20,21].  The PLGA 
fibres with different treatments were mounted onto sample studs by double-sided 
adhesive carbon tapes.  XPS measurements were made using an ESCALAB MKII 
spectrometer (VG Scientific) with a Mg Kα X-ray source (1253.6 eV photons) at a 
constant dwell time of 100 ms.  Pass energy was 20 eV and anode current was 20 mA.  
Pressure in the analysis chamber was 5×10−10 mbar, and sample-analyser angle was 75 
degrees.  All binding energies were referenced to the C 1s photoelectron peak at 284.6 
eV. 
3.2.3.3 Collagen release experiment 
A quantity of 10 mg of PLGA fibres was immobilised in collagen solution by 
physical coating or grafting as described above.  PLGA fibres were freeze-dried after 
washing with PBS at different time points.  Amount of collagen on the surface of 
PLGA fibres was then measured by DC protein assay (Bio-Rad Laboratries, USA).  
Briefly, the PLGA fibres were transferred into a 1.5-mL centrifuge tube, and 1 mL of 
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reagent B and 125 μL of mixed solution of reagents A and S were added into each tube.  
All tubes were maintained at room temperature for 30 min, before 200 μL of the 
resulting solution was transferred into a 96-well plate.  Absorbance readings were 
taken using a microplate reader (Safire2, Tecan) at a wavelength of 750 nm. 
3.2.3.4 Compression modulus of scaffold 
Dried scaffolds were fabricated into a plate shape (18 mm length, 9 mm width, and 
3 mm thickness).  Compression test was done at room temperature on an Instron 
MicroTester 5848 (Canton, MA, USA) at a speed of 0.5 mm/min  at a temperature of 
25±2°C.  Compression modulus was then calculated from the slope of the initial 
linear portion of the stress-strain curve.  Five scaffolds were tested for each group. 
3.2.3.5 Porosity measurement by mercury porosimeter 
The internal structure parameters of PLGA-collagen scaffold — pore size 
distribution, total pore area, and porosity, were measured by a PASCAL 140 mercury 
porosimeter (Thermo Finnigan, Italy) with S-CD6 dilatometer.  Measurement 
technique was based on the principle that the external pressure required to force a non-
wetting liquid (mercury) into a pore, against the opposing force of liquid surface 
tension, depended on the pore size — as shown in Washburn’s equation below: 
P = 4×δ×cosθ/d 
where P is the applied pressure and d is the pore diameter.  Moreover, the following 
assumptions were used: (1) shape of the pores was cylindrical; (2) contact angle 
between mercury and pore wall, θ, was 140o; and (3) surface tension of mercury, δ, 
was 480 dyne/cm. 
 Chapter 3  PLGA-collagen hybrid scaffold
 
 Page 3-8 
 
Scaffold preparation and measurement were performed according to 
manufacturer’s instructions.  In brief, scaffold sample was weighed and placed into the 
dilatometer, which was closed by tightening the greased cap.  The mercury charging 
process started by degassing the diameter under vacuum, which continued until the 
required degree of vacuum was attained (0.02 Pa).  When the required vacuum degree 
was reached, the transducer for analysis was automatically zero-calibrated at every run 
and the system proceeded with mercury filling operation up to a pre-selected volume 
level (800 mL).  Once the mercury charging operation was completed, the analysis 
began and the pressure was increased from vacuum at a rate determined by the 
PASCAL system.  Upon reaching the maximum pressure (400 kPa), the sample was 
depressurized at a rate determined by the PASCAL system again.  The experimental 
data were memorized in an on-board microprocessor and kept in the internal memory 
buffer. 
3.2.4 Cell culture 
3.2.4.1 Hepatocyte isolation 
Adult male inbred Wistar rats (Animal Holding Unit, National University of 
Singapore, Singapore) weighing 200 to 300 g were used in this study.  Animals were 
housed in the Animal Holding Facility, Department of Experimental Surgery, National 
University Hospital, for the entire duration of the experiment.  Housing and feeding 
were done according to NIH guidelines for the care of laboratory animals. 
Hepatocytes were harvested by a modified two-step in situ collagenase perfusion 
method [22].  In brief, each rat was given 100 U/kg of heparin before anaesthesia.  
After 30 min, pentobarbital was administered intraperitoneally at a dose of 30 mg/kg.  
After laparotomy, a portal cannula was fixed in a position along the portal vein.  A cut 
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was rapidly made in the lower vena cava.  A pre-perfusion with calcium-free perfusion 
buffer was performed in the initial 2–3 min to wash out any remaining blood in the 
blood vessels, at a flow rate of 50 mL/min.  Upon completing pre-perfusion, the liver 
was transferred into a stainless steel mesh cone supported by a 400 mL glass baker.  
The liver was perfused by re-circulating 0.05% collagenase buffer for 30 min.  This 
was terminated when the vena cava ruptured.  The entire perfusion procedure was 
performed under oxygenation that greatly improved cell viability. 
Cells were liberated from the connective vascular tissue and re-suspended in fresh 
DMEM cell culture medium by forceps.  Cell suspension was then filtered through a 
nylon mesh with a 60-μm pore size to further remove connective tissue debris.  The 
filtrate was centrifuged at 30 g for 2 min to obtain a cell pellet.  The cells were 
collected and washed twice with DMEM cell culture medium.  Viability of the 
hepatocytes was determined to be 90–95% based on the conventional trypan blue 
exclusion test. 
3.2.4.2 Culture condition 
Hepatocytes were cultured in Williams’ E medium supplemented with 10 mmol/L 
nicotinamide (Sigma−Aldrich), 0.2 mmol/L ascorbic acid 2-phosphate 
(Sigma−Aldrich), 20 ng/mL epidermal growth factor, 20 mmol HEPES (Gibco),  
0.5 μg/mL insulin, 0.1 μmol/L dexamethasone, 100 U/mL penicillin G, and  
100 μg/mL streptomycin.  The hepatocytes were seeded into the scaffolds at a cell 
density of 2.0×106 cells/cm3.  Scaffolds with hepatocytes were cultured in 12-well 
plates in a cell culture incubator (37°C, 95% humidity and 5% CO2). 
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3.2.4.3 Cell morphology 
The morphology of hepatocytes in hybrid PLGA-collagen scaffold was 
characterised by SEM.  Samples were fixed with glutaraldehyde (3% in PBS) for  
30 min at room temperature.  After repeated rinsing in PBS, constructs were further 
fixed with an aqueous solution of osmium tetraoxide (OsO4) (1%) for 30 min at room 
temperature.  After dehydration through a graded ethanol series (25%, 50%, 75%, 95% 
and 100%), the scaffolds were freeze-dried in −50°C and 30 mmPa overnight.  
Samples were cut into 2 mm thickness with a razor blade and gold-coated with an ion 
sputter coater at 30 mA for 80 seconds.  Images were acquired with a scanning 
electron microscope. 
3.2.4.4 Cell attachment and metabolism activity of hepatocytes in 
scaffold 
The number of hepatocytes attached to the scaffold after 24 h of cell seeding was 
evaluated by quantifying the DNA content of a crude cellular homogenate of the 
hepatocytes using PicoGreen dsDNA Quantitation Kit (Molecular Probes).  Cells 
were lysed by incubating in 3 mL of 1 M NaOH, followed by incubation for 30 min at 
70°C.  After cell lysis, the pH of cell lysate was adjusted back to 7.0 with 3 M 
potassium acetate and 1 M HCl.. 
A volume of 100 μL of 200-fold dilution of PicoGreen dye in buffer was added to 
100 μL of the cell lysate, and the mixture was incubated for 5 min at room temperature.  
Fluorescence measurements were obtained using a microplate reader (Safire2, Tecan) 
with an excitation wavelength of 480 nm and an emission wavelength of 520 nm.  A 
standard curve was plotted by measuring a known number of cells.  Cell number in the 
scaffold was then determined from the standard curve. 
 Chapter 3  PLGA-collagen hybrid scaffold
 
 Page 3-11 
 
To study the metabolism activity of hepatocytes in the scaffolds, the colorimetric 
AlamarBlue™ assay (BioSource International Inc., Camarillo, USA) was used.  
Briefly, the scaffolds were rinsed with PBS, followed by incubation with 10% 
AlamarBlue™ reagent in serum-free culture medium for 3 h.  Aliquots were then 
pipetted into 96-well plates and placed into a microplate reader.  Absorbance readings 
at 570 nm and 600 nm of each well were measured by microplate reader. 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Scaffold fabrication 
We sought to fabricate a hybrid PLGA-collagen scaffold that combined the 
advantages of both PLGA and collagen for tissue engineering application.  To this end, 
we embedded collagen-grafted PLGA fibres in collagen sponge to form a hybrid 
PLGA-collagen scaffold.  To enhance the interfacial stability between PLGA fibres 
and collagen, collagen was grafted onto PLGA fibres by means of a chemical bond 
between the collagen molecules and PLGA chains, which thus rendered the collagen 
grafting stable under prolonged culture conditions. 
The surface modification process was divided into three steps.  First, the surface of 
PLGA fibres was functionalised by hydrolysis.  Secondly, the functional groups on the 
surface of PLGA fibres were activated by EDC/NHS.  Lastly, chemical bonds were 
formed between the carboxyl groups (−COOH) of the PLGA chains on the fibre 
surface and the amino groups (−NH2) of collagen molecules.  Figure 3.1 presents 
schematically the details of the surface modification process. 
Hydrolysis of PLGA fibres was conducted under basic conditions, where the 
hydrolysis reaction took place preferentially on the material surface rather than in the 
bulk material [14,23].  This is demonstrated in Figure 3.2 where the surface of PLGA 
fibres was smooth after hydrolysis.  During the hydrolysis reaction, hydroxyl anions 
hydrolysed the ester groups on the surface of PLGA fibres, resulting in the breakage of 
the polymer chain and the formation of a carboxyl group and a hydroxyl group on the 
termini of the two new chains.  Consequently, the diameter of PLGA fibres was 
reduced.  The decrease in diameter of PLGA fibres was proportional to the hydrolysis 
time, as shown in Figure 3.3. 
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Figure 3.2 SEM images of PLGA fibres with different hydrolysis treatments: (a) pristine PLGA 
fibres; (b) PLGA fibres hydrolysed for 20 min; (c) PLGA fibres hydrolysed for  
30 min; (d) PLGA fibres hydrolysed for 50 min (n=5, mean±SD). 
 
Figure 3.3 Diameters of PLGA fibres at different hydrolysis times in 0.1 N NaOH solution (n=5, 
mean±SD) 
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From the XPS survey results shown in Figure 3.4, the higher oxygen peak on the 
surface of hydrolysed PLGA fibres, as compared to that of pristine PLGA fibres, was 
consistent with the addition of hydroxyl groups during the hydrolysis reaction.  
Hydrolysis at multiple regions on the same polymer chain reduced the polymer to 
smaller fragments, thereby resulting in the decreased diameter of PLGA fibres, as 
shown in Figures 3.2 and 3.3. 
 
Figure 3.4 XPS survey scan spectra of PLGA fibre surface with different treatments:  
(a) pristine PLGA fibres; (b) PLGA fibres treated with 0.1 N NaOH for 30 min;  
(c) PLGA fibres physically coated with collagen; (d) PLGA fibres grafted with 
collagen 
Collagen grafting on PLGA fibres was carried out after carboxyl group generation 
on PLGA fibres by hydrolysis and activation with EDC/NHS.  Chemical bonds were 
formed between amino groups of collagen and carboxyl groups on PLGA fibre surface 
after the grafting process.  In Figure 3.4, it was found that: (1) only carbon and oxygen 
peaks, corresponding to C 1s (binding energy of 284.6 eV) and O 1s (binding energy 
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of 532 eV), were present in the spectra of pristine PLGA fibres (Figure 3.4(a)) and 
PLGA fibres treated with 0.1 M NaOH for 30 min (Figure 3.4(b)).  However, the 
relative intensities of both C 1s and O 1s peaks varied in these two spectra; (2) a new 
peak corresponding to N 1s (binding energy of 400 eV) appeared on the spectra of 
PLGA fibres physically coated with collagen (Figure 3.4(c)) and PLGA fibres grafted 
with collagen (Figure 3.4(d)) after extensive washing in deionised water for 2 h.  This 
peak was higher in the spectrum of PLGA fibres grafted with collagen than that of 
PLGA fibres physically coated with collagen.  As the magnitude of the nitrogen peak 
contributed by the amino groups of collagen could be used as a marker to indicate the 
amount of collagen present on the fibre surface, it might be concluded that there was 
more collagen on the surface of PLGA fibres grafted with collagen than on the surface 
of PLGA fibres physically coated with collagen after extensive washing in deionised 
water.  No collagen was present on the surface of pristine PLGA fibres or hydrolysed 
PLGA fibres. 
Figure 3.5 shows the N 1s core level spectra of: (a) pristine PLGA fibres;  
(b) PLGA fibres treated with 0.1 M NaOH for 30 min; (c) PLGA fibres physically 
coated with collagen; and (d) PLGA fibres grafted with collagen.  A peak 
corresponding to N 1s (binding energy of 400 eV) appeared on the spectra of PLGA 
fibres physically coated with collagen or grafted with collagen.  The level of nitrogen 
peak contributed by collagen was a good indicator of the amount of collagen on the 
fibre surface.  Consistent with the observations in Figures 3.4(c) and (d), there was 
more collagen on the surface of collagen-grafted PLGA fibres than on  
collagen-coated PLGA fibres.  Again, similar to Figures 3.4(a) and (b), no collagen 
was present on the surface of pristine PLGA fibres or hydrolysed PLGA fibres. 
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Figure 3.5 XPS N 1s core level spectra for PLGA fibre surface with different treatments: (a) 
pristine PLGA fibres; (b) PLGA fibres treated with 0.1 M NaOH for 30 min;  
(c) PLGA fibres physically coated with collagen; (d) PLGA fibres grafted with 
collagen 
Figures 3.6(a) and (b) show respectively the C 1s core level spectra of pristine 
PLGA fibres and PLGA fibres treated with 0.1 M NaOH for 30 min.  Only a major 
neutral carbon (C-H) peak appeared at binding energy of 284.6 eV and two minor 
peaks at binding energies of 286.5 eV  and 288.8 eV, which represent C-O and C=O 
respectively.  For the spectra of PLGA fibres physically coated with collagen (Figure 
3.6(c)) and PLGA fibres grafted with collagen (Figure 3.6(d)), two new peaks 
associated with C-N and O=C-N appeared at binding energies of 285.7 eV and 287.6 
eV respectively.  It should be highlighted that in the two spectra of Figures 3.6(c) and 
(d), their integrated areas of the two new peaks differed — once again showing that 
less collagen was present on the surface of PLGA fibres physically coated with 
collagen than on PLGA fibres grafted with collagen.  As for the chemical bond formed 
between the surface carboxyl groups of PLGA fibres and the amino groups of collagen, 
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better collagen stability was yielded on the surface of PLGA fibres grafted with 
collagen — even after extensive washing in deionised water (Figure 3.7). 
 
Figure 3.6 XPS C 1s core level spectra for PLGA fibre surface with different treatments: 
(a) pristine PLGA fibres; (b) PLGA fibres treated with 0.1 M NaOH for 30 min; 
(c) PLGA fibres physically coated with collagen; (d) PLGA fibres grafted with 
collagen 
 
Figure 3.7 Collagen release profiles in PBS of collagen-grafted PLGA fibres and PLGA fibres 
physically coated with collagen (n=5, mean±SD) 
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Fabrication of fibrous scaffolds with synthetic polymers is usually associated with 
the use of toxic chemicals or extreme temperature ranges.  In this study, these 
conditions were avoided during scaffold fabrication.  The hybrid PLGA-collagen 
scaffold was produced by filling the spaces between fibres with collagen solution, 
followed by lyophilisation to form a microporous structure for cell infiltration and 
growth.  Finally, a collagen crosslinking reaction took place to further stabilise the 
scaffold, as shown in Figure 3.8.  In Figure 3.9, it was demonstrated that good 
attachment between collagen and PLGA fibres resulted in well-interconnected 
channels in the hybrid PLGA-collagen scaffold.  The mechanical property of this 
scaffold was characterised by compression test.  Compression modulus was used as an 
indicator of the scaffold’s resistance against external forces — which would cause the 
microstructure in the scaffold to collapse and further inhibit cell migration and 
nutrition supply.  The compression modulus of hybrid PLGA-collagen scaffold was 
50-fold higher than that of commercially available collagen sponge (Figure 3.10). 
 
Figure 3.8 Digital photograph of PLGA-collagen scaffold fabricated by freeze-drying of surface-
modified PLGA fibres blended in collagen solution (6 mg/mL) 
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Figure 3.9 Cross-sectional SEM photographs of scaffolds: (a) collagen scaffold; (b) unmodified 
PLGA scaffold with crosslinked collagen; (c) surface-modified PLGA scaffold with 
crosslinked collagen 
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Figure 3.10 Compression modules of scaffolds with different treatments: (a) collagen sponge;  
(b) PLGA-collagen scaffold (without crosslinking); (c) PLGA-collagen scaffold (with 
crosslinking).  (n=5, mean±SD). 
The microstructure of the scaffold in terms of pore size distribution, total pore area, 
and porosity — was characterised by PASCAL 140 mercury porosimeter and SEM.  
The porosity of crosslinked PLGA-collagen scaffold was 81%, indicating that the 
structure was highly porous[24].  The average total surface area was 0.032 m2 per 
scaffold (18×9×3 mm) and the mean pore radius was 51±23 μm.  A typical plot of pore 
diameter distribution is illustrated in Figure 3.11.  In terms of SEM observation, 
collagen appeared as integrated extensions of the PLGA fibres and acted as 
interconnected channels, thereby providing space for cell seeding and culturing, as 
well as efficient mass transfer and waste elimination. 
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Figure 3.11 Scaffold microstructure.  A typical pore size distribution of crosslinked  
PLGA-collagen scaffold, as measured by mercury porosimeter, is represented by 
relative pore volume (□).  The latter is defined as the volume percentage of pores 
with a specific radius to total pore volume.  Cumulative volume (━) which is defined 
as summation of volumes of pores with pore size beyond a specific radius. 
3.3.2 Cell culture 
Hepatocytes were seeded as a sensitive cell model (anchorage-dependent cells 
highly sensitive to environmental cues) in the hybrid PLGA-collagen scaffold, and cell 
attachment and metabolism activity of hepatocytes in this scaffold were thereby 
examined.  Figure 3.12 shows the hepatocytes’ attachment in the hybrid PLGA-
collagen scaffold.  As predicted, hepatocytes attached well to both the collagen-grafted 
PLGA fibres and the collagen strips — which filled in the spaces between the fibres in 
the hybrid PLGA-collagen scaffold.  The number of cells attached to the scaffold was 
also quantified by their DNA content after 24 h of culture. 
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The DNA content of hepatocytes attached in each scaffold was characterised by 
PicoGreen dsDNA Quantitation assay.  Figure 3.13 shows the number of 
hepatocytes attached to the scaffold.  Cell number in the hybrid PLGA-collagen 
scaffold was the highest probably due to the following reasons: (1) there were more 
interconnected channels in the hybrid PLGA-collagen scaffold than the control 
scaffolds (collagen sponges and PLGA-collagen scaffold without collagen grafting) — 
hence, more surface area was available for cell attachment and more passages for cell 
infiltration in cell seeding for the hybrid PLGA-collagen scaffold ; (2) the surface of 
collagen-grafted PLGA fibres was more hydrophilic than that of unmodified PLGA 
fibres, thus facilitating cell attachment [16,17]. 
Using AlamarBlue™ assay, the metabolism activity of hepatocytes in the hybrid 
PLGA-collagen scaffold was compared against that of control PLGA scaffold, with 
data normalised against the DNA content in each scaffold (Figure 3.14).  It was 
apparent that the metabolism activity of hepatocytes in the hybrid PLGA-collagen 
scaffold was higher than that of the control PLGA scaffold.  The high metabolism 
activity of hepatocytes could probably be attributed to the highly biocompatible nature 
of collagen. 
 
Figure 3.12 SEM micrograph of hepatocytes cultured in hybrid PLGA-collagen scaffold (24 h 
after cell seeding) 
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Figure 3.13 Number of hepatocytes attached to the different scaffolds with different treatments: 
(a) collagen sponge; (b) PLGA-collagen scaffold (without surface modification);  
(c) PLGA-collagen scaffold at 24 h after cell seeding (n=3, mean±SD) 
 
Figure 3.14 AlamarBlue assay for hepatocytes cultured in different scaffolds with different 
treatments: (a) collagen sponge; (b) PLGA-collagen scaffold (without crosslinking); 
(c) PLGA-collagen scaffold (with crosslinking) at 24 h after cell seeding.  (n=3, 
mean±SD). 
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3.4 CONCLUSIONS 
In this study, a novel, unstructured, hybrid scaffold consisting of random-blended, 
collagen-grafted PLGA microfibres and crosslinked collagen was developed thus: 
PLGA fibres were surface-modified by hydrolysis and EDC/NHS chemistry, and then 
underwent lyophilisation with collagen solution followed by collagen crosslinking.  It 
was found that the hydrolysis reaction took place preferentially on the surface of 
PLGA fibres, thereby resulting in reduced diameter of fibres — which was inversely 
proportional to hydrolysis time.  XPS results confirmed that collagen molecules were 
successfully grafted onto the surface of PLGA fibres.  Compression test indicated that 
this hybrid PLGA-collagen scaffold had better mechanical properties than those of 
collagen alone. 
SEM and pore size distribution revealed that this scaffold had a highly 
interconnective, porous microstructure with diversity of pore sizes — thereby 
mimicking the physical structure of native ECMs.  Furthermore, the primary cultures 
of rat hepatocytes in this hybrid scaffold demonstrated these favourable characteristics: 
(1) good cellular affinity of scaffold; and (2) high metabolism activity of hepatocytes 
cultured in this scaffold. 
In light of the abovementioned features and experimental findings, this novel, 
hybrid scaffold proved to have potential applications as a tissue engineering substrate, 
since it favourably inherited the advantages of both synthetic polymer and natural 
polymer in terms of cell response and scaffold fabrication. 
 
 Chapter 3  PLGA-collagen hybrid scaffold
 
 Page 3-25 
 
BIBLIOGRAPHY 
1. Langer R, Vacanti JP.  Tissue engineering.  Science 1993; 260(5110):920−926. 
2. Stevens MM, George JH.  Exploring and engineering the cell surface interface.  
Science 2005; 310(5751):1135−1138. 
3. Ogawa K, Vacanti JP.  Liver.  In: Atala A, Lanza RP (editors), Methods of tissue 
engineering, New York: Academic Press, 2002, pp.977−986. 
4. Mikos AG, Temenoff JS.  Formation of highly porous biodegradable scaffolds for 
tissue engineering.  Electr J Biotech 2000; 3(2):116−119. 
5. Pierschbacher MD, Ruoslahti E.  Cell attachment activity of fibronectin can be 
duplicated by small synthetic fragments of the molecule.  Nature 1984; 
309(5963):30−33. 
6. Jose F, Alvarez-Barreto VIS.  Improved mesenchymal stem cell seeding on RGD-
modified poly(L-lactic acid) scaffolds using flow perfusion.  Macromol Biosci 2007; 
7(5):579−588. 
7. Ma L, Gao C, Mao Z, Zhou J, Shen J.  Enhanced biological stability of collagen 
porous scaffolds by using amino acids as novel cross-linking bridges.  Biomaterials 
2004; 25(15):2997−3004. 
8. Hiraoka Y, Kimura Y, Ueda H, Tabata Y.  Fabrication and biocompatibility of 
collagen sponge reinforced with poly(glycolic acid) fibre.  Tissue Eng 2003; 
9(6):1101−1112. 
9. Chen G, Ushied T, Tateishi. T.  Fabrication of PLGA-collagen hybrid sponge.  
Chem Lett 1999; 28:561−562. 
10. Badylak SF.  Modification of natural polymers: collagen.  In: Atala A, Lanza RP 
(editors), Methods of tissue engineering, New York: Academic Press, 2002, 
pp.505−514. 
11. Mikos AG, Bao Y, Cima LG, Ingber DE, Vacanti JP, Langer R.  Preparation of 
poly(glycolic acid) bonded fibre structures for cell attachment and transplantation.  J 
Biomed Mater Res 1993; 27(2):183−189. 
12. Hasirci V, Berthiaume F, Bondre SP, Gresser JD, Trantolo DJ, Toner M.  
Expression of liver-specific functions by rat hepatocytes seeded in treated poly(lactic-
co-glycolic) acid biodegradable foams.  Tissue Eng 2001; 7(4):385−394. 
13. Mooney DJ, Sano K, Kaufmann PM, Majahod K, Schloo B, Vacanti JP.  Long-
term engraftment of hepatocytes transplanted on biodegradable polymer sponges.  J 
Biomed Mater Res 1997; 37(3):413−420. 
 Chapter 3  PLGA-collagen hybrid scaffold
 
 Page 3-26 
 
14. Croll TI, O’Connor AJ, Stevens GW, Cooper-White JJ.  Controllable surface 
modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis.  I: 
Physical, chemical, and theoretical aspects.  Biomacromolecules 2004; 5(2):463−473. 
15. Mikos AG, Lyman MD, Freed LE, Langer R.  Wetting of poly(L-lactic acid) and 
poly(DL-lactic-co-glycolic acid) foams for tissue culture.  Biomaterials 1994; 
15(1):55−58. 
16. Freed LE, Marquis JC, Nohria A, Emmanual J, Mikos AG, Langer. R.  Neo-
cartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable 
polymers.  J Biomed Mater Res 1993; 27:11−23. 
17. Fiegel HC, Havers J, Kneser U, Smith MK, Moeller T, Kluth D.  Influence of 
flow conditions and matrix coatings on growth and differentiation of three-
dimensionally cultured rat hepatocytes.  Tissue Eng 2004; 10(1−2):165−174. 
18. Cheng ZY, Teoh SH.  Surface modification of ultra thin poly(epsilon-
caprolactone) films using acrylic acid and collagen.  Biomaterials 2004; 
25(11):1991−2001. 
19. Wissink MJB, Beernink R, Pieper JS, Poot AA, Engbers GHM, Beugeling T.  
Immobilization of heparin to EDC/NHS-crosslinked collagen.  Characterization and in 
vitro evaluation.  Biomaterials 2001; 22(2):151−163. 
20. Yin C, Ying L, Zhang PC, Zhuo RX, Kang ET, Leong KW.  High density of 
immobilized galactose ligand enhances hepatocyte attachment and function.  J Biomed 
Mater Res (A) 2003; 67A(4):1093−1104. 
21. Ying L, Yin C, Zhuo RX, Leong KW, Mao HQ, Kang ET.  Immobilization of 
galactose ligands on acrylic acid graft-copolymerized poly(ethylene terephthalate) film 
and its application to hepatocyte culture.  Biomacromolecules 2003; 4(1):157−165. 
22. Seglen P.  Preparation of isolated rat liver cells.  Methods Cell Biol 1976; 
13:29−83. 
23. Gao J, Niklason L, Langer R.  Surface hydrolysis of poly(glycolic acid) meshes 
increases the seeding density of vascular smooth muscle cells.  J Biomed Mater Res 
1998; 42(3):417−424. 
24. Yang F, Xu CY, Kotaki M, Wang S, Ramakrishna S.  Characterisation of neural 
stem cells on electrospun poly(L-lactic acid) nanofibrous scaffold.  J Biomat Sci-












 Chapter 4  Perfusion coculture 
 
 Page 4-1 
 
4.1 INTRODUCTION 
In the development of effective BAL devices and reliable surrogate tissues for cell-
based liver therapies, one of the most significant challenges lies in the design of a 
functional scaffold/substrate that could support the maintenance of a mass of highly 
functional and viable hepatocytes [1−4].  Recent studies have shown that the functions 
of cultured hepatocytes could be enhanced or maintained by several tissue engineering 
strategies [5−10].  Amongst which is the modulation of hepatocyte culture parameters 
to mimic the microenvironment in vivo, such as: 
(a) Culturing isolated hepatocytes in a 3D, biocompatible scaffold.  Cell fate can be 
modified by altering cytoskeletal organisation, whereby the latter is achieved through 
culturing in a 3D organisation and diversity of specific cell surface molecular 
interactions; 
(b) Culturing under flow conditions, in which mass transport of oxygen, nutrients 
and waste products is enhanced through a perfusion culture in the bioreactor system; 
and 
(c) Coculturing hepatocytes with several types of supporting cells including liver-
derived and non-liver-derived cells, so that in vivo physical and chemical interactions 
between cells can be partly preserved in vitro.  In particular, enhancement of 
hepatocyte functions can occur through TGF-β paracrine signalling [11] or static 
coculture of hepatocytes and hepatic stellate cells without direct cell-cell contact 
[12,13]. 
In light of the abovementioned tissue engineering strategies, this study set out to 
achieve the following: 
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Â Develop a dual-compartment bioreactor, which enables serial perfusion 
coculture of two different types of cells in PLGA-collagen scaffold developed in 
Chapter 3 to become feasible; and 
Â Investigate the effects of HSC-T6 on the liver-specific functions of hepatocytes 
through separate coculturing in the dual-compartment bioreactor over a 9-day period. 
With regard to the new bioreactor, it was designed to facilitate serial perfusion 
coculture of hepatocytes with HSC-T6 in a 3D, biodegradable PLGA-collagen scaffold.  
The 3D PLGA-collagen scaffold consisted of collagen-grafted PLGA microfibres 
embedded in collagen sponge, thereby providing both adequate strength and 
appropriate cell attachment property.  Hepatocytes and HSC-T6 cells were then seeded 
in individual PLGA-collagen scaffolds in two separate compartments of bioreactor for 
perfusion culturing. 
As for the effects of HSC-T6 on liver-specific functions of the hepatocytes 
cocultured in the PLGA-collagen scaffold, the findings were encouraging.  The 
hepatocytes exhibited enhanced differentiated functions — such as albumin secretion 
and urea synthesis — as compared to the monoculture system where hepatocytes alone 
were cultured.  In other words, this result implied the potential applicability of this 
PLGA-collagen scaffold containing hepatocytes cocultured with HSC-T6 in BAL 
devices. 
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4.2 EXPERIMENTAL DETAILS 
4.2.1 Materials 
Besides the materials used in Chapter 3, ethoxyresorufin-O-deethylase (EROD) 
and resorufin were obtained from Sigma−Aldrich Pte Ltd (Singapore).  Urea synthesis 
kit was purchased from Stanbio Laboratory (Boerne, TX, USA), while Albumin 
ELISA kit was purchased from Bethyl Laboratories Inc. (Montgomery, TX, USA).  
4.2.2 Scaffold preparation 
PLGA-collagen scaffolds were fabricated as described previously [14].  The 
process included grafting of collagen onto the surface of PLGA fibres, lyophilisation 
and crosslinking.  Prior to cell seeding in the scaffolds, all scaffolds were sterilised by 
exposure to a 60Co irradiator (Gammacell 220 Excel, Canada) until a total dose of  
25 kGy was achieved. 
4.2.3 Perfusion bioreactor system assembly 
The perfusion bioreactor consisted of two polycarbonate compartments, one 
peristaltic pump, gas exchange tubings and one culture medium reservoir (Figure 4.1).  
Dimensions of the bioreactor were given as follows with the details shown in Figures 
4.2−4.4: 
 Inner dimensions of the upper compartment were: 20 mm length, 10 mm width, 
6 mm height.  Inner dimensions of the lower compartment were: 20 mm length, 10 mm 
width, 9 mm height. 
 Dimensions of the scaffold holder plate were: 20 mm length, 10 mm width, 3 
mm thickness, with diameter of distribution holes at 3 mm. 
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 Thickness of bioreactor wall was 6 mm. 
 Thickness, pore size and open area of separation membrane were 90 µm, 6 µm 
and 5% respectively (Sefar Petex 07-6/5, Sefar AG). 
All components were connected with silastic tubing (Dow Corning Corporation, 
Midland, USA) of 2 mm inner diameter.  Compartments were separated by a scaffold 
holder plate.  Culture medium was perfused from the lower compartment to the upper 
compartment via medium distribution holes in the scaffold holder plate.  A separation 
membrane prevented cross-contamination of cells in the two compartments.  Prior to 
perfusion culture, all components of the bioreactor were sterilised by gamma 
irradiation with a total dose of 25 kGy. 
Flow rates were optimized using albumin secretion by hepatocytes as determined 
by the Albumin ELISA kit.  Lactate and glucose concentrations were measured by 
analysing 0.5 mL of the culture medium in a BioProfile 400 Analyser (Nova 
Biomedical, Waltham, USA).  Glucose consumption was derived by measuring the 
difference in glucose concentration between the fresh medium and perfused medium 
after 24 h of perfusion.  The amount of lactate released was obtained by measuring the 
perfused medium after 24 h of perfusion.  Results were obtained from three different 
cell populations. 
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Figure 4.2  Details of scaffold holder and accessories 
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Figure 4.3  Details of the upper compartment of bioreactor 
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Figure 4.4  Details of the lower compartment of bioreactor 
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4.2.4 Hepatocyte isolation and culture 
Adult male inbred Wistar rats (Animal Holding Unit, National University of 
Singapore, Singapore) weighing 200 to 300 g were used in this study.  Housing and 
feeding were done according to NIH and NACLAR guidelines for the care of 
laboratory animals.  All experimental protocols employed in this study were approved 
by the IACUC Committee of the National University of Singapore. 
Hepatocytes were harvested by a two-step in situ collagenase perfusion method as 
described in Chapter 3.  Viability of the hepatocytes was determined to be 90–95% 
based on the conventional trypan blue exclusion test[15]. 
The rat stellate cell line, HSC-T6, used in this study was granted as a gift from Dr. 
Scott Friedman (Mount Sinai School of Medicine, New York, NY, USA).  The HSC-
T6 stellate cell line was established from male Sprague−Dawley rats at passage 
number 56 [16]. 
Dulbecco’s modified Eagle medium was used during the cell isolation process.  
Hepatocytes and HSC-T6 cells were cocultured in Williams’ E medium supplemented 
with 10 mmol/L nicotinamide, 0.2 mmol/L ascorbic acid 2-phosphate, 20 ng/mL 
epidermal growth factor, 20 mmol HEPES, 0.5 μg/mL insulin, 44 mmol/L NaHCO3, 
0.1 μmol/L dexamethasone and 0.1 % bovine serum albumin. 
4.2.4.1 Hepatocytes and HSC-T6 seeding and culture 
Scaffolds were placed in culture dishes on ice for 10 min before cell seeding 
commenced.  Hepatocytes (4×106 cells/scaffold) and HSC-T6 cells (2×106 
cells/scaffold) were re-suspended in 0.4 ml of culture medium respectively, and then 
injected into the scaffolds using a 1-mLsyringe with 18 G needle. 
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4.2.4.2 Static culture 
Cell-seeded scaffolds were kept in 6-well culture plates with 5 mL of culture 
medium; incubated at 37°C temperature, 95% humidity and 5% CO2.  Culture medium 
was changed every two days.  Albumin secretion and urea production in the culture 
medium were measured every 48 h. 
4.2.4.3 Perfusion culture 
For the monoculture, a hepatocyte-seeded scaffold was placed into the upper 
compartment of the bioreactor, while the lower compartment was kept empty.  For 
coculture, hepatocyte- and HSC-T6-seeded scaffolds were placed into the upper and 
lower compartments of bioreactor respectively, and perfusion-cultured at 37°C, 95% 
humidity, and 5% CO2, with a peristaltic flow rate of 1.2 mL/min as shown in Figure 
4.5.  Culture medium was changed every two days, and albumin secretion and urea 
production in the culture medium were measured every 48 h. 
 
Figure 4.5  Perfusion bioreactor system in incubator 
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4.2.5 Cell morphology characterisation by scanning electron 
microscopy 
The morphology of hepatocytes in the scaffolds was characterised by SEM.  
Details of sample preparation and SEM settings were the same as those described in 
Chapter 3. 
4.2.6 DNA quantification and cell number 
The total numbers of cells attached to the scaffolds were evaluated by quantifying 
the DNA content in scaffolds using PicoGreen dsDNA Quantitation Kit.  Details of 
sample preparation and data acquisition were the same as those described in Chapter 3. 
4.2.7 Albumin ELISA assay 
By maintaining the colloid osmotic pressure of plasma, albumin plays an important 
role in maintaining plasma volume and tissue fluid balance.  In this study, albumin 
secretion rate from hepatocytes was determined by a sandwich enzyme-linked 
immunosorbent assay (ELISA).  For static culture, medium samples were harvested 
from culture supernatant at 24 h after fresh medium change.  For perfusion culture, 
medium samples were harvested from the medium reservoir at 24 h after fresh medium 
change.  Medium samples were then frozen at −80°C for analysis. 
Polystyrene 96-well plates (Costar, Corning Incorporated, Corning, USA) were 
coated with 10.0 µg/mL of capture antibody (Sheep anti-Rat Albumin, Bethyl 
Laboratories Inc., Montgomery, TX, USA) in coating buffer (pH 9.6).  After allowing 
overnight adsorption at 4°C temperature, contents of the plates were washed three 
times with a washing buffer (0.05% Tween 20 in Tris buffer, pH 8).  Following which, 
the wells were filled with a blocking buffer (2.5% BSA in Tris buffer, pH 8) and 
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incubated overnight at 4°C to prevent non-specific reactions.  The contents were then 
discarded and the wells washed three times with washing buffer. 
Samples and standards were prepared with a diluent buffer (2.5% BSA and 0.05% 
Tween 20 in Tris buffer, pH 8) and incubated in the 96-well plate at room temperature 
for 2 h.  After which, contents of the wells were discarded and the wells washed five 
times with washing buffer. Detection antibody in diluent buffer at 0.1 µg/mL was 
incubated in 96-well plate for 2 h at room temperature.  After which, contents of the 
wells were discarded and the wells washed five times with washing buffer.  A stable 
peroxidase substrate buffer (0.05 M phosphate-citrate buffer, pH 5.0) containing o-
phenylenediamine-dihydrochloride was used to develop colour.  The colour reaction 
was stopped by adding 2.0 M sulphuric acid, and optical density was determined at 
490 nm using a microplate reader (Safire2, Tecan Austria GmbH). 
4.2.8 Urea synthesis assay 
Ammonia metabolism is a major function of the liver.  Liver cells synthesise urea 
from absorbed ammonia to reduce its concentration in blood.  To induce urea synthesis 
of hepatocytes in the culture system, ammonium chloride was added to fresh culture 
medium to a final concentration of 1 mM for both static and perfusion culture.  For the 
static culture, scaffolds were incubated for 2 h in ammonium chloride-doped medium.  
After which, the medium was collected as sample and a subsequent 30-min incubation 
in fresh medium was performed to remove residual ammonium chloride-doped 
medium.  Similarly for the perfusion culture, subsequent incubation in fresh perfusion 
culture medium for 30 min was performed after ammonium chloride-doped medium 
was circulated through the perfusion system for 2 h to produce samples. 
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Both samples of static and perfusion culture were centrifuged at 10,000 rpm for 
4 min and the supernatant subjected to urea analysis using a Colorimetric Assay Kit 
(Stanbio Laboratory, Boerne, TX, USA).  Briefly, a volume of 70 μL of sample was 
added to a 400-μL mixture of BUN Acid and Colour reagents (with a ratio of 2:1) in 
1.5 mL Eppendorf microcentrifuge tubes.  Then, the tubes were placed in a heat block 
of 95°C to be shaken at 500 rpm and 10 min for reaction.  After reaction, all the tubes 
were cooled in ice water for 5 min and centrifuged for 1 min at 6000 rpm.  The 
supernatant was added into a 96-well plate, and optical density of each well was 
determined at 520 nm using a microplate reader (Safire2, Tecan Austria GmbH).  A 
standard curve was plotted by measuring a known concentration of urea.  Urea 
production by hepatocytes cultured in the scaffolds was then determined from the 
standard curve. 
4.2.9 Cytochrome P450 function assay 
In this study, the xenobiotic biotransformation function of hepatocytes which 
converts xenobiotics and drugs into hydrophilic compounds, was characterised by 
cytochrome P450-1A1/2 activity in terms of ethoxyresorufin conversion to resorufin 
(ethoxyresorufin-O-deethylase) (EROD).  Procedural details of the protocol were 
adopted from pervious paper [17]. 
Ethoxyresorufin (ER) concentration was independently determined from both the 
absorbance at a wavelength of 480 nm and from the fluorescence of resorufin (R).  
Fluorescence was measured at an excitation wavelength of 543 nm and at an emission 
wavelength of 570 nm.  Measured fluorescence was corrected by subtracting the 
contribution from the remaining ER, and net R production was determined by a 
calibration curve. 
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4.3 RESULTS 
4.3.1 Perfusion bioreactor for serial coculture 
Hepatocytes and HSC-T6 cells were seeded in separate 3D PLGA-collagen 
scaffolds and placed in the upper and lower compartments of the bioreactor 
respectively (Figure 4.5).  Overnight leakage test was performed prior to the perfusion 
culture.  After the cell-containing scaffolds were placed in the bioreactor, all 
connectors, tubings, and bioreactor enclosures were sealed securely.  Perfusion culture 
was initiated, and culture medium level in the reservoir was monitored regularly.  No 
culture medium leakage from the perfusion bioreactor was observed.  Visual 
observations of the transparent bioreactor, tubings and reservoir indicated good 
stability of the scaffolds with no signs of fungal or bacterial contamination for up to 9 
days of perfusion culture. 
Flow rate in the perfusion bioreactor was optimised against albumin secretion by 
the hepatocytes (Figure 4.6).  A range of flow rates from 0.33 to 4.00 mL/min was 
estimated to yield reasonable cellular functions in hepatocyte perfusion culture [18].  
In our perfusion bioreactor, the optimal flow rate was 1.20 mL/min, which yielded the 
highest level of albumin secreted by hepatocytes.  To investigate the delivery of 
nutrients and oxygen in the perfusion bioreactor for both monoculture and serial 
coculture, lactate and glucose concentrations in the culture medium were measured 
over a period of 9 days (Figure 4.7).  Results indicated that lactate and glucose 
concentrations for both monoculture and serial coculture conditions were kept below 
0.7 g/L and within 1.6−2.3 g/L respectively. 
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Figure 4.6 Effect of flow rates on albumin secretion by hepatocytes cultured in perfusion 
bioreactor, (○) 0.33 mL/min, (■) 0.66 mL/min, (△) 1.2 mL/min, (▽) 4 mL/min.(n=3, 
mean±SD) 
 
Figure 4.7 Lactate and glucose concentrations — in the perfusion bioreactor under (△) 
monoculture and (▲) coculture conditions — were quantified at various time points 
during the 9-day culture under a perfusion flow rate of 1.2 ml/min.  Data are   
represented as mean±SD (n=3). 
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4.3.2 Serial coculture of hepatocytes and HSC-T6 
The coculture ratio of hepatocytes and HSC-T6 cells was optimised against 
albumin secretion by hepatocytes, and the optimum hepatocytes to HSC-T6 ratio was 
2:1.  Hepatocytes and HSC-T6 cells cocultured in 3D scaffolds after 9 days of serial 
perfusion in the bioreactor were imaged by SEM (Figure 4.8).  It could be seen that 
both hepatocytes and HSC-T6 maintained a cuboidal cell morphology. 
Albumin secreted by hepatocytes cultivated under all conditions increased 
gradually during the first 5 days of culture, and then decreased until day 9 (Figure 4.9).  
The albumin secreted by hepatocytes on day 5 in serial perfusion coculture was more 
than 5-fold higher than that of hepatocytes in static culture, and 1.5-fold higher than 
that of hepatocytes in perfusion monoculture.  Overall, albumin secretion of 
hepatocytes in serial perfusion coculture with HSC-T6 was maintained at a higher 
level throughout the 9 days of culture. 
The urea synthesis function of hepatocytes was assessed by exposing the cells to 
culture medium containing 1 mM NH4Cl for 2 h (Figure 4.10).  In serial perfusion 
coculture of hepatocytes with HSC-T6, urea production by hepatocytes on day 6 was 
10-fold higher than that of hepatocytes in static culture, and 1.3-fold higher than that of 
hepatocytes in perfusion monoculture. 
Phase I xenobiotic biotransformation function of hepatocytes, measured by 
cytochrome P450-dependent EROD assay, revealed that hepatocytes cultured in serial 
perfusion coculture maintained a relatively higher level of cytochrome P450 
expression than that of hepatocytes in static culture after 9 days of culture (Figure 
4.11).
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Figure 4.8 Scanning electron micrographs of modified PLGA fibre scaffold with hepatocytes 
and HSC-T6 cocultured on day 9 
 
 
Figure 4.9 Albumin secretion rates of hepatocytes under various culture conditions during 9-
day culture.  All data were quantified and normalised against the DNA content in 
each scaffold.  Data are represented as mean±SD (n=3). 
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Figure 4.10 Urea production rates of hepatocytes under various culture conditions during 9-day 
culture.  All data were quantified and normalised against the DNA content in each 
scaffold.  Data are represented as mean±SD (n=3). 
 
Figure 4.11 Cytochrome P450 1A1/2 activities of hepatocytes in term of EROD were quantified 
and normalised against the DNA content in each scaffold.  Data are represented as 
mean±SD (n=3). 
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4.4 DISCUSSION 
For the development of effective BAL devices and reliable cell-based therapies, 
maintenance of a mass of highly functional and viable hepatocytes for long term 
cultivation in vitro is a challenge [19,20].  Several researchers have shown that a 
number of factors influence the viability and functions of hepatocytes: culture in 3D 
organisation, interactions with neighbouring cells and improvement of mass transfer 
for nutrients and oxygen [5,21−25].  In particular, hepatocytes are anchorage-
dependent cells which require a stable substrate surface to stimulate attachment, 
survival, reorganisation and functions [26].  Therefore, a scaffold is required not only 
to serve as a substrate for cell support , but also wields a profound influence on the 
modulation of cell adhesion and gene expression, relevant to cell growth and liver-
specific functions [27] — which was the desired intent for the development of PLGA-
collagen hybrid scaffold in Chapter 3. 
Furthermore, high-density hepatocyte packing in BAL devices or cell-based 
therapies is essential to support a patient’s failing liver.  On this note, a porous 
microstructure in 3D scaffolds has two relevant benefits: increase the surface-to-
volume ratio for efficient cell attachment, as well as promote good mass transfer of 
oxygen and nutrients [1,26,28].  In this study, therefore, the PLGA-collagen scaffold 
was intended to be used in a dual-compartment bioreactor, by virtue of a mass of 
hepatocytes packed in a scaffold with adequate mechanical strength [14].  At the same 
time, it was also intended to provide appropriate stimulation to hepatocytes via specific 
interactions between hepatocytes and collagen [29].Furthermore, to stabilize cell-cell 
interactions and cell-substrate interactions between hepatocytes and scaffold in 
perfusion culture, a seamless integration of collagen sponges with PLGA fibres was 
achieved via surface modification of PLGA fibres in Chapter 3. Through collagen 
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release profile, it was suggested that the amount of remaining collagen after extensive 
rinsing was relatively high on the surface of modified PLGA fibres.  This was thus an 
apparently positive indication on two fronts: improved collagen adhesion to the surface 
of collagen-conjugated PLGA fibres and stabilized microporous collagen sponges in 
inter-fibre spaces [14]. 
In order to maintain cell viability in bulky scaffolds with high resistance to mass 
transport, perfusion bioreactors have been extensively used for cell cultures to enhance 
supply of nutrients and oxygen supply and waste removal [5,28,30,31].  On this note, 
perfusion bioreactor was designed and developed in this study with a view to 
coculturing hepatocytes and HSC-T6 cells in the 3D PLGA-collagen scaffold.  
Optimal flow rate (1.2 mL/min) in the bioreactor was determined against albumin 
secretion by hepatocytes.  One interpretation of this result would be that when the flow 
rate was too low, mass transfer of nutrients, oxygen and metabolites could not meet the 
requirements for optimal maintenance of hepatocytes functions.  Conversely, when the 
flow rate was too high, the hydrodynamic shear stress generated could be detrimental 
to the hepatocytes [32]. 
Mammalian cells utilise glucose for energy production and produce lactate as a 
metabolic by-product.  In most cases, glucose is the limiting nutrient in the medium 
whereby its concentration may affect cell growth [33].  When glucose concentration is 
maintained at a level higher than 0.6 g/L, cell growth will not be limited by glucose 
level [34].  Lactate, produced mainly as a metabolic by-product of glucose metabolism, 
is also an important indicator of cell growth and metabolic activities.  However, a high 
level of lactate (>2 g/L) inhibits mammalian cell growth [35].  It should also be noted 
that release of lactate is characteristic of aerobic cell metabolism in the culture [30].  In 
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the present study, glucose level was maintained within 1.6−2.3 g/L and lactate level 
was maintained below 0.7 g/L in both monoculture and coculture conditions.  In other 
words, the delivery of nutrients and oxygen in the culture medium under both 
conditions was sufficient throughout the entire culture period [30,33]. 
HSC is a major non-parenchymal cell type in the liver, producing various 
biologically active mediators to regulate the behaviour of hepatocytes.  Hepatocyte, on 
the other hand, also influences HSC by expressing insulin-like growth factor 
[11,36−38].  However, previous studies on the coculture of these two cell types with 
direct cell-cell contact reported a decrease in hepatocyte function [12,13].  On this note, 
HSC-T6 and hepatocytes were separated in this study by a polymeric membrane.  
Membrane thickness and pore size were discerningly selected to be adequate for 
separating the bulk of cells in the two compartments, while allowing efficient mass 
transfer in perfusion culture.  Consequently, higher levels of hepatic functions such as 
albumin production, urea synthesis, and cytochrome P450 enzymatic activity were 
expressed by hepatocytes under serial perfusion coculture with HSC-T6 cells, as 
compared to perfusion monoculture or static monoculture. 
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4.5 CONCLUSION 
A new perfusion bioreactor, comprising two separate compartments, was designed 
and developed for the serial coculture of hepatocytes and HSC-T6 cells in 3D PLGA-
collagen scaffolds..  The differentiated functions of hepatocytes in this bioreactor were 
maintained at a higher level compared to the monoculture system where hepatocytes 
alone were perfused or statically cultured.  Results obtained showed that the dual-
compartment perfusion bioreactor successfully enabled independent control of 
supporting cells such as HSC-T6.  Thus, it is suggested that a local environment could 
be “tailor-made” or customised for different applications in BAL devices and cell-
based therapies devices.  Furthermore, it also implied the potential applicability of this 
PLGA-collagen scaffold containing hepatocytes cocultured with HSC-T6 in BAL 
devices. 
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5.1 INTRODUCTION 
Apart from the PLGA-collagen hybrid scaffold discussed in Chapter 3, this 
chapter focuses on another type of hybrid scaffold which employed a structure-based 
design.  This novel scaffold leveraged on a 3D, porous PCL scaffold, which was 
fabricated by the highly reproducible and computer-controlled fused deposition 
modelling technique (FDM) [1,2]. 
To date, 3D, porous, polymeric scaffolds have been intensively considered in many 
biomedical applications.  For example, they have been proposed as substrates in tissue 
engineering for cell attachment, proliferation and differentiation under a three-
dimensional organisation — the same as that would occur in vivo [3−6].  Additionally, 
they also have been proposed as drug delivery systems so that drug release is timed 
more accurately and distributed more uniformly [7−9]. 
However, two limitations plague the 3D polymeric scaffolds in their application 
status as ideal substrates in tissue engineering.  The first limitation arises from a lack 
of specific domains on the surface of most polymeric scaffolds for cells or drugs to 
form stable complexes or undergo specific interactions [10−13].  It should be 
mentioned that the viability and functionality of cells depends not only on the 3D 
organisation of cells with their neighbours, but also on specific interactions between 
the cells and the substrate [4,14,15].  In the event of unstable interactions, burst release 
of drugs loaded in the polymeric porous scaffold would occur, thereby jeopardising the 
effectiveness and safety of drug delivery [13]. 
The second drawback arises from traditional scaffolds with a poorly defined 
structure, such that it negatively affects the morphology and functions of cells [3,16].  
Presently, tissue scaffolds are fabricated by various technologies [17−24].  However, 
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few of these scaffolds have a well-defined structure.  Previous studies have been 
shown that cell behaviour was influenced by scaffold architecture [16,25].  As such, to 
generate consistent and reproducible outcome for liver tissue engineering applications, 
scaffolds with a well-defined 3D structure are an important factor. 
To overcome the abovementioned limitations, numerous strategies entailing 
surface chemistry and/or scaffolds with a well-defined structure have been advocated 
[25−33].  Amongst which, surface grafting is one such prominent surface modification 
strategy to control the interactions between the surface of polymeric materials and cells 
or drugs [34−38].  By means of covalent bonding, this strategy enables a desired high 
density of specific domains to be immobilised for establishment of specific interactions 
between surface of polymeric scaffolds and cells/drugs [12,14].  The common 
approach for surface grafting is to generate active free radicals on the polymeric 
scaffold surface initially, so that specific domains are covalently bonded either directly 
or indirectly (through space linkage) — to the surface of the polymeric scaffold.  In 
particular, the indirect linkage serves for a variety of specific domains with amplified 
effect [36]. 
Up to now, most of the successful surface grafting strategies for scaffolds are 
restricted to a two-dimensional configuration.  Hence, it remains a great challenge to 
efficiently control the uniformity and stability of surface chemistry in bulky, three-
dimensional, porous scaffolds [10,39−42]. 
Of late, computer-controlled fused deposition modelling (FDM) technique has 
been utilized to generate three-dimensional scaffolds with predefined structures [1].  
FDM allows layer-by-layer construction of complex, three-dimensional PCL scaffolds 
by applying a computer model to control manufacture.  However, the minimum pore 
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size produced by this method is about 100 μm, which in many cases may not be small 
enough for liver tissue engineering applications [3]. 
Against this backdrop of a need to uniformly control surface chemistry in a three-
dimensional scaffold with a well-defined structure, the objectives of this study were: 
(1) To develop a means to uniformly graft collagen onto the surface of bulky, 
biodegradable, 3D, porous polymeric scaffolds, from the interior to the periphery at a 
depth of 6 mm. 
(2) To form a hybrid porous PCL-collagen scaffold whereby the microstructure 
provides a conducive environment for cell cultures. 
(3) To evaluate the feasibility of using this hybrid PCL-collagen scaffold to 
construct surrogate tissues. 
In this chapter, a three-dimensional, porous polymeric scaffold with a relatively 
well-defined structure was fabricated, coupled with a uniform and stable 
immobilization of collagen molecules on the surface from the interior to the periphery.  
The strategies used were given as follows: 
Â Surface grafting of collagen on the surface of 3D, porous PCL scaffold via 
gamma induction; 
Â Gelation of collagen solution in interspaces between surface-modified PCL 
microfibres by gamma irradiation to form a hybrid PCL-collagen scaffold. 
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As for the advantages of our method, they are listed as follows: 
& There is no need for chemical initiators, hence making gamma-initiated surface 
grafting attractive for medical applications.  This is especially so for bulky, 
implanted scaffolds, whereby initiators are difficult to be washed out [43−45]. 
& As gamma ray has an inherently deeper penetration ability, it has the capability 
for uniform generation of free radicals on the inner and outer surfaces of 
scaffolds without forming any dead spaces, which is the first and essential step 
in most surface modification strategies [44,46−49]. 
& Gamma treatment can impede homopolymerisation formation [50] owing to 
absence of photoirradiation and high reaction temperature during grafting step, 
which are otherwise necessary for surface modification of many polymeric 
scaffolds via plasma, UV and ozone methods [34,51−53].  It should be 
mentioned that when homopolymerisation products are trapped inside a three-
dimensional porous scaffold, they are difficult to be washed out, especially in a 
bulky scaffold.  As such, the surface grafting process, cell seeding and mass 
transfer of nutrients, oxygen or exchange of metabolites around cells in the 
scaffold will be further hampered.  Although high-energy irradiation may cause 
chain scission/crosslinking in polymers, the extent and end-result of these 
effects are highly dependent on the dose absorbed. 
& Gelation of collagen solution in surface-modified structure defined PCL 
scaffold resulted in a relatively well-defined structure for the PCL-collagen 
scaffold, and at the same time provided smaller pore structures and cell-like 
substrate fit for tissue engineering applications. 
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5.2 EXPERIMENTAL DETAILS 
5.2.1 Materials 
PCL pellets (Catalog No. 440744) from Aldrich Chemical Co. Inc. (Milwaukee, 
WI, USA) were used.  The polymer had a number average molecular weight (Mn) of 
80,000 with a melt index of 1.0 g/10 min.  N-hydroxysuccinimide (NHS) was supplied 
Pierce (Research Instruments, Singapore).  Acrylic acid, ethanolamine, 2-(N-
morpholino)-ethanesulfonic acid (0.1 M MES), N-(3-dimethylaminopropyl)-N'-
ethylcarbodiimide hydrochloride (EDC) and epidermal growth factor (EGF) were 
obtained from Sigma−Aldrich Pte Ltd (Singapore).  Dulbecco’s modified Eagle 
medium (DMEM), Williams’ E medium and insulin were purchased from Invitrogen 
Singapore Pte Ltd.  Vitrogen collagen solution (3 mg/ml) dissolved in 0.012 N HCl 
was purchased from Cohesion Technologies Inc. (California, USA).   
5.2.2 Scaffold preparation 
PCL scaffold was synthesised as previously described [1].  It was produced by 
Osteopore International Pte Ltd (The Alpha, Science Park 2, Singapore) with a lay-
down pattern of 0/60/120 degree. In brief, pellets of PCL (catalog no. 440744) from 
Aldrich Chemical Co., Inc. (Milwaukee, WI) were used. The polymer has an average 
number-average molecular weight (Mn) of 80,000 with a melt index of 1.0 g/10 min. 
The polymer pellets were kept in a desiccator prior to usage. Filament fabrication was 
performed with a fiber-spinning machine (Alex James & Associates Inc., Greensville, 
SC). The pellets were melted at 190 °C in a cylinder with an external heating jacket. 
After a hold time of 15 min, the temperature was lowered to 140 °C and the polymer 
melt was extruded through spinnerets with a die exit diameter of 0.064 in. (1.63 mm). 
Each batch of PCL pellets weighed 30 ± 1 g. The piston speed was set at 10 mm/min. 
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The extrudate was quenched in chilled water placed 40 mm below the die exit. The 
combination of temperature, piston speed, and height drop to water quenching settings 
produced a filament diameter of 1.70 ± 0.10 mm. The PCL filaments were fabricated 
to have a consistent diameter to fit the drive wheels of the Fused Deposition Modeling 
(FDM) system. The filaments were vacuum-dried and kept in a desiccator prior to 
usage. The next step is scaffold design and fabrication. The PCL filaments were fed 
into a FDM 3D Modeler RP system from Stratasys Inc. (Eden Prairie, MN). Stratasys 
QuickSlice software was manipulated to produce the desired dimensions. The head 
speed, fill gap, and raster angle for every layer were programmed through this software 
and saved in the Slice file format. Lay-down patterns of 0/60/120° were used to give a 
honeycomb, fully interconnected matrix architecture.  After manufacturing, the 
specimens were cut with a blade into small cuboids of 10×10×6 mm dimensions.  
These cuboids were washed with ethanol for 1 h and dried prior to surface 
modification. 
5.2.2.1 Surface modification of three-dimensional porous PCL scaffold 
The surface modification process of three-dimensional, porous PCL scaffolds by 
gamma induction is schematically shown in Figure 5.1 and described below. 
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Figure 5.1 Schematic representation of the process of gamma-induced AAc grafting and 
collagen immobilisation of three-dimensional, porous PCL scaffolds 
Free radical formation: To generate free radicals on the surface of PCL scaffolds, 
dried, pre-cleaned, cuboidal PCL scaffolds were placed in a gamma irradiator 
(Gammacell 220, MDS Nordion, Canada) of which the gamma ray source was 60Co 
and the dose rate was 10 kGy/h, so as to achieve a total absorbed dose of 10 kGy as 
shown in Figure 5.3. 
Cuboidal PCL scaffolds were packed in 50-ml polystyrene centrifuge tubes which 
were filled to capacity with argon, and the tubes were chilled in ice in a 2-litre glass 
baker.  Absorbed radiation dose of the cuboidal PCL scaffolds was controlled by the 
exposure time of the glass baker under gamma irradiation.  After the cuboidal PCL 
scaffolds absorbed the desired radiation dose, the tubes containing cuboidal PCL 
scaffolds were stored immediately in liquid nitrogen to preserve the radicals formed. 
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Carboxylation: For carboxylation, 50 ml of 10% (v/v) acrylic acid (AAc) aqueous 
solution distilled under vacuum was degassed by bubbling argon through it for 30 min.  
It was then transferred to a vertical tube reactor fitted with vertical capillary to allow 
argon to flow through during the whole carboxylation process, as shown in Figure 5.4.  
Pre-irradiated, three-dimensional, porous PCL scaffolds were taken from liquid 
nitrogen storage and transferred into the degassed AAc solution for reaction with AAc 
for 10 min under a stream of argon at 30°C.  After reaction, the carboxylated PCL 
scaffolds were removed and washed extensively with deionised water for two days to 
remove residues adsorbed on the surface. 
Collagen immobilisation: With regard to collagen immobilisation on the surface of 
PCL scaffolds, carboxylated PCL scaffolds were conjugated with collagen molecules 
by EDC/NHS chemistry.  Briefly, the carboxylated PCL scaffolds were immersed in 
MES buffer (10 mM, pH 5.5) containing 400 mM EDC and100 mM NHS.  After two 
hours of EDC/NHS activation at room temperature, the MES solution was completely 
removed and replenished with 100 ml of phosphate buffer (0.1 M) containing 0.3 
mg/ml of collagen type I.  In this manner, collagen molecules were allowed to 
conjugate with carboxyl groups on the surface of 3D, porous PCL scaffolds at 4°C 
overnight.  After collagen conjugation, all the scaffolds were quenched with 0.5% (v/v) 
ethanolamine solution for three hours to deactivate the functional carboxylic groups, 
and then washed extensively with deionised water for two days. 
Surface modification on PCL scaffolds by plasma induction was set as a control 
against that by gamma induction.  The process is schematically shown in Figure 5.2 
and described below. 
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Figure 5.2 Schematic representation of the process of plasma-induced AAc grafting and 
collagen immobilisation of three-dimensional, porous PCL scaffolds 
Peroxide formation: Dried, pre-cleaned, cuboidal PCL scaffolds were placed 
between two electroplates and subjected to argon plasma treatment by SAMCO Basic 
Plasma Kit (Model BP-1, SAMCO International Inc. Japan) operating at a radio 
frequency (RF) of 13.6 MHz, as shown in Figure 5.5.  Argon was introduced into the 
plasma chamber at a flow rate of 50 mL/min with chamber pressure maintained at 20 
Pa.  Plasma was generated at an electric power of 40 W for 5 min.  After plasma 
treatment, the cuboidal PCL scaffolds were exposed to atmosphere for 10 mins to 
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effect the formation of surface peroxides, which were required to facilitate the 
subsequent UV-induced graft polymerisation of AAc. 
Carboxylation: For carboxylation, quartz tubes of 12 cm length and 2.5 cm 
diameter were fabricated at the Glassware workshop of the Department of Chemistry 
at National University of Singapore.  The plasma-treated PCL scaffold was immersed 
in 50 mL of the aqueous solution containing 3% AAc in the quartz tube.  Argon was 
bubbled through the solution to thoroughly remove oxygen.  The quartz tube was 
capped tightly and placed in a water bath with a constant temperature of 28°C and 
subjected to UV irradiation for 30 min using a 400 W flood lamp in an UV-F 400 unit 
(Panacol−Elosol GmbH, Germany).  After carboxylation, PCL scaffolds were taken 
out of the tubes and washed extensively with deionised water for 24 h to remove 
residues adsorbed on the surface. 
Collagen immobilisation: Details of collagen immobilisation on the surfaces of 
three-dimensional, porous PCL scaffolds carboxylated by plasma induction were the 
same as those by gamma induction. 
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Figure 5.3 Apparatus for free radical generation in three-dimensional, porous PCL scaffolds by 
gamma induction 
 
Figure 5.4 Apparatus for carboxylation on the surface of three-dimensional, porous PCL 
scaffolds 
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Figure 5.5 Apparatus for peroxide formation on the surface of three-dimensional, porous PCL 
scaffolds 
5.2.2.2 Fabrication of hybrid PCL-collagen scaffold 
3D, porous, hybrid PCL-collagen scaffold was fabricated by gelation of collagen 
solution into the surface-modified PCL scaffolds by gamma irradiation, followed by 
lyophilisation.  Briefly, each surface-modified PCL scaffold was immersed in a 20-mL 
glass bottle containing 8 ml of 6 mg/mL collagen solution and centrifuged in a high-
performance centrifuge (Avanti J-25, Beckman Coulter, USA) under these conditions: 
20,000 rpm for 10 mins at 4°C.  This was done to ensure that the surface-modified 
PCL scaffold was fully infiltrated with collagen solution without any remaining dead 
spaces.  Then, the centrifuge bottles with surface-modified PCL scaffold and collagen 
solution were chilled in ice in a 2 L ice glass baker and exposed to gamma irradiation 
for a total absorbed dose of 10 kGy.  After washing in deionised water for 2 days, each 
scaffold was frozen at –80°C and lyophilized to obtain a hybrid scaffold consisting of 
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collagen sponges embedded in three-dimensional, porous PCL scaffold.  After two 
days of lyophilisation, the scaffolds were dried and stored in a desiccator.  Prior to cell 
culture experiments, the scaffolds were sterilised by exposure to a 60Co source until a 
total absorbed dose of 25 kGy was achieved. 
5.2.3 Scaffold characterisation 
5.2.3.1 Characterisation of free radicals by electron paramagnetic 
resonance (EPR) spectroscopy 
Free radicals generated in PCL scaffold by gamma induction were characterised by 
EPR.  EPR spectra were acquired with a Bruker Elexsys E500 X-band (9−10 GHz) 
CW-EPR spectrometer (Bruker BioSpin Gmbh, Germany).  Samples were stored in 
liquid nitrogen and analysed in 5-mm-diameter quartz tubes.  Prior to use, an open tube 
in the resonator was connected to the purge gas of purified nitrogen gas.  The spectra 
were acquired at room temperature with a microwave power of 2 mW, modulation 
amplitude of 1 G and a frequency of 100 kHz.  Deconvolution of spectra was 
performed by Bruker Xepr software. 
5.2.3.2 Characterisation of morphology by scanning electron 
microscopy (SEM) 
The morphologies of 3D, porous PCL scaffolds subjected to different treatments 
were observed with a JSM-7400M field emission scanning electron microscope.  PCL 
scaffolds were cut into blocks of 2 mm thickness with a razor blade and mounted onto 
sample studs by double-side adhesive carbon tapes.  Scaffold cross-sections were gold-
coated with an ion sputter, JEOL JFC-1200 fine coater, at 30 mA for 80 s prior to 
observation by SEM at a voltage of 5 kV. 
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5.2.3.3 Characterisation of morphology by atomic force microscopy 
(AFM) 
Following SEM, morphologies of PCL scaffolds were also examined with a 
higher-resolution AFM (Veeco NanoScope IV MultiMode) in air.  PCL scaffolds were 
cut into blocks of 2 mm thickness with a razor blade and mounted onto glass cover 
slides by double-sided adhesive carbon tapes.  AFM images were obtained by scanning 
the surface with tapping mode (scan size: 1×1 μm; scan rate: 1.00−1.90 Hz) using a 
silicon nitride probe. 
5.2.3.4 X-ray photoelectron spectroscopy (XPS) measurement 
XPS was used for identifying and quantifying elements and specific species on the 
surface of samples.  PCL scaffolds were cut into blocks of 2 mm thickness with a razor 
blade.  Cross-sections of scaffolds of different treatments were mounted onto sample 
studs by double-sided adhesive carbon tapes.  XPS measurements were made with 
Quantera Scanning X-ray Microprobe (ULVAC-PHI) with Al Kα X-ray source 
(1486.7eV photons).  Pass energies were 224 eV (survey scan) and 55 eV (narrow 
scan).  X-ray source was operated at 40 W, 15 kV and 200 μm beam size, and pressure 
in the analysis chamber was approximately 2×10−8 Torr (usually in low 10−8 Torr 
range).  Core level signals were obtained at a photoelectron takeoff angle of 90° to the 
sample surface.  A survey scan spectrum was taken from 200−600 eV, and the N 1 s 
core level signal was used as a marker for analysis of relative amount of collagen 
immobilised on the surface.  In conjunction with ion sputtering, elemental distributions 
in the direction of penetration to the surface of PCL scaffolds were determined by XPS 
too.  All XPS results were analysed by XPSPEAK Version 4.1 software.  All binding 
energies were referenced to the C 1s photoelectron peak at 284.6 eV. 
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5.2.3.5 Time-of-flight secondary ion mass spectrometry (ToF-SIMS) 
measurement 
ToF-SIMS (TOF SIMS 5, ION-TOF GmbH, Germany) was also used for 
identifying elements and specific species on the surface of samples in this study.  PCL 
scaffolds were cut into blocks of 2 mm thickness with a razor blade.  Cross-sections of 
PCL scaffolds of different treatments were mounted onto a sample holder, fixed by 
spring clamps and transferred into the analysis chamber.  Analysis was performed 
using a current of 2 pA, a voltage of 25 keV, a sputter time of 400 s, an acquisition 
time of 400 s, an analysis area of 500 μm2, a cycle time of 100 μs, and recording of 
negative ion spectra at 0–200 amu.  All data were normalised using total ion current. 
5.2.3.6 Toluidine blue O (TBO) assay 
Carboxyl groups on the surface of carboxylated PCL scaffolds were quantified by 
TBO assay as described previously [12], but with some modifications.  PCL scaffolds 
were cut into blocks of 2 mm thickness with a razor blade.  Cross-sections of PCL 
scaffolds of different treatments were incubated in 3 mL of TBO solution (0.5 mM in 
0.1 mM NaOH, pH 10) in a 12-well culture plate for 5 h at room temperature under 
constant shaking.  Uncomplexed dye was removed by washing with excess amount of 
NaOH solution (pH 10) two times (3 h each time).  Complexed TBO on the surface of 
carboxylated PCL scaffolds was desorbed from the surface by incubating scaffold 
sections in 3 mL of 50% acetic acid solution for 5 h under constant shaking. 
TBO concentration in acetic acid solution was determined by its optical density 
measured at 633 nm with a microplate reader (Safire2, Tecan).  Carboxyl group density 
on the surface was calculated from complexed TBO content, assuming that TBO 
complexes with the carboxyl groups on the scaffold surface at 1:1 ratio. 
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5.2.3.7 Acid Orange II (AO) assay 
Acid Orange II assay was used for determining the degree of functionalisation, i.e., 
the density of primary and secondary amine groups on the surface [42,54] of collagen-
immobilised PCL scaffolds.  Collagen-immobilised PCL scaffolds were cut into blocks 
of 2 mm thickness with a razor blade.  Cross-sections of PCL scaffolds of different 
treatments were immersed in a solution of 500 μM Acid Orange II in deionised water 
at pH 3 at which there is a protonation of amines.  After shaking overnight at room 
temperature, the cross-sections were washed twice with deionised water at pH 3.  
Amount of bound dye was quantified after detachment in deionised water at pH 12, 
which was achieved after 30 mins of shaking at room temperature.  This was because 
deprotonation of amines occurred at basic pH values. 
AO concentration in deionised water was determined by its optical density 
measured at 492 nm with a microplate reader (Safire2, Tecan).  Surface density of 
amine groups was quantified by comparison with a standard curve of known 
concentrations of amine groups. 
5.2.3.8 Tensile strength measurement  
PCL pellets were fed in between two heated rolls, which were heated up to 80°C 
with a rolling speed of 1 rpm.  The pellets melted completely and formed a highly 
viscous liquid layer which adhered on the two-roll mill (Brabender, OHG Duisburg, 
Germany).  The PCL layer was collected by using a blade to scrape off the viscous 
mass from the roller surface.  The roll-milled mass collected was sandwiched between 
two aluminium foils and melt-pressed into a film at 80°C and at a pressure of 30 MPa.  
After 10 min, the sandwiched film was allowed to slowly cool under pressure for 12 h. 
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The mechanical properties of the PCL films were characterised with a tabletop 
Instron Micro Tester 5848 apparatus (Instron Corp., Canton, MA, USA) using a low-
force load cell of 20 N.  Strip-shaped specimens (30×6 mm2) were tested at a 
crosshead speed of 5 mm/min.  Ambient conditions were set at 25±2°C and 74±1% 
humidity.  Thickness of PCL films for measurement with a digital micrometer was 
around 300 μm.  Mechanical properties such as ultimate strength and elongation were 
acquired from the generated tensile stress-strain curves.  
5.2.3.9 Differential scanning calorimetry (DSC) test 
Thermal analysis of the PCL scaffolds after gamma irradiation was conducted on a 
Perkin-Elmer Model DSC Series-4 (Waltham, Massachusetts, USA) equipped with a 
Thermal Analysis Data Station (TADS) using standard aluminium pans.  Nitrogen was 
used as a sweep gas.  Measurements were made on ca. 10 mg samples and a nitrogen 
atmosphere (flow rate = 50 mL/min) was used throughout, in a temperature range 
between −80 and 90°C and at a heating or cooling rate of 10°C/min.  The instrument 
was calibrated with an indium standard. 
The samples were heated at a rate of 10°C/min under a nitrogen gas flow 
protection for the DSC measurements.  Heat of fusion was reported from the first 
heating scan, and heat of crystallization and crystallization temperature were reported 
from the first cooling scan.  Melting temperature (Tm) was reported as the peak value 
of the melting endotherms.  Crystallinity was calculated according to the following 
equation: 
Xc (%) = (△Hf /△H°f) × 100 
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where △Hf is the measured heat of fusion of sample, and △H°f is the heat of fusion 
for 100% crystalline PCL.  △H°f of crystalline PCL is 3.69 kcal/mole or 135 J/g [56]. 
5.2.3.10 Compression modulus of scaffold 
Dried PCL-collagen scaffolds were cut into blocks (5 mm length, 5 mm width and 
6 mm thickness).  Compression tests were done at room temperature on an Instron 
MicroTester at a speed of 0.5 mm/min and at a temperature of 25±2°C.  Compression 
modulus was calculated from the slope of the initial linear portion of stress-strain curve. 
5.2.3.11 Porosity measurement by mercury porosimeter 
The internal microstructure of PCL-collagen scaffolds was characterised by a 
mercury porosimeter.  Details of the method were described in Chapter 3.  Briefly, the 
internal structure parameter of PCL-collagen scaffolds — in terms of pore size 
distribution, total pore area and porosity, were measured using a PASCAL 140 
mercury porosimeter (Thermo Finnigan Italia SpA, Italy) with S-CD6 dilatometer.  
Sample preparation and measurement were performed according to instructions from 
the manufacturer. 
5.2.4 Cell culture 
5.2.4.1 Hepatocyte isolation 
Details of hepatocyte isolation method are already given in Chapter 3.  Briefly, 
adult male inbred Wistar rats (Animal Holding Unit, National University of Singapore, 
Singapore) weighing 200 to 300 g were used in this study.  Hepatocytes were 
harvested by a modified two-step in situ collagenase perfusion method.  Viability of 
the hepatocytes was determined to be 90–95% based on the conventional trypan blue 
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exclusion test. 
5.2.4.2 Culture condition 
Hepatocytes were cultured for the required amount of time in Williams’ E medium 
supplemented with 10 mmol/L nicotinamide (Sigma−Aldrich), 0.2 mmol/L ascorbic 
acid 2-phosphate (Sigma−Aldrich), 20 ng/mL epidermal growth factor, 20 mmol 
HEPES (Gibco),0.5 μg/mL insulin, 0.1 μmol/L dexamethasone, 100 U/mL penicillin G, 
and 100 μg/mL streptomycin.  Hepatocytes were seeded into the scaffolds at a cell 
density of 1.8×106 cells/scaffold (as determined using a hemacytometer).  Scaffolds 
with hepatocytes were cultured in 12-well plates in a cell culture incubator (37°C, 95% 
humidity and 5% CO2). 
5.2.4.3 Cell morphology in scaffold 
The morphology of hepatocytes in PCL-collagen scaffold was characterised by 
SEM.  Samples were fixed with glutaraldehyde (3% in PBS) for 30 min at room 
temperature.  After repeated rinsing in PBS, constructs were further fixed with an 
aqueous solution of osmium tetraoxide (OsO4) (1%) at 4oC for 30 min at room 
temperature.  After washing with deionised water and dehydration through a graded 
ethanol series (25%, 50%, 75%, 95% and 100%), the scaffolds were dried by 
hexamethyldisilazane.  Dried scaffolds were cut into 2 mm thickness with a razor 
blade and gold-coated with an ion sputter coater (JEOL JFC-1200) at 15 mA for 60 s.  
SEM micrographs were acquired with a field emission scanning electron microscope 
(JSM-7400M). 
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5.2.4.4 Cell attachment and metabolism activity of hepatocytes in 
scaffold 
The number of hepatocytes attached to the scaffold after 24 h of cell culture was 
evaluated by quantifying the DNA content of a crude cellular homogenate of the 
hepatocytes using PicoGreen dsDNA Quantitation Kit (Molecular Probes) as 
described in Chapter 3.  The metabolism activity of hepatocytes cultured in different 
scaffolds was examined using the colorimetric AlamarBlue™ assay (BioSource 
International Inc., Camarillo, USA) as described in Chapter 3. 
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5.3 RESULTS AND DISCUSSION 
5.3.1 Surface modification of three-dimensional porous PCL scaffold 
5.3.1.1 Characterisation of free radicals 
EPR spectroscopy was used for identifying and quantifying the free radicals 
formed in 3D, porous PCL scaffolds in this study.  Figure 5.6A shows the relationship 
between the amount of free radicals generated and absorbed gamma radiation dose in 
PCL scaffolds, while the stability of free radicals generated in PCL scaffolds is also 
shown in Figure 5.6B.  It was found that the total amount of free radicals generated 
(0−2.78×1016 spin/g) depended on the gamma dose absorbed in the PCL scaffolds 
(0−20 kGy).  Free radicals formed by gamma irradiation were unstable in air when not 
under continuous irradiation, such that the total amount of free radicals decreased from 
2.78 to 0.3×1016 with time (0−42 min).  The results obtained were consistent with 
previous studies, which speculated that the secondary alkyl ether radicals created in 
PCL were a result of protons lost by high energy irradiation.  Moreover, these radicals 
were unstable at room temperature as they were prone to decaying by recombination 
[43,45,57−59]. 
Figure 5.6 (A) Relationship between amount of free radicals generated in PCL scaffold and the 
amount of gamma irradiation dose absorbed by PCL scaffold; (B) Stability of free 
radicals induced by gamma irradiation in PCL scaffold in air 
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5.3.1.2 Morphology characterisation 
The surface morphologies of pristine, carboxylated and collagen-immobilised PCL 
scaffolds examined by SEM are shown in Figures 5.7A, B and C (low-magnification 
images on the left side, and high-magnification images on the right side).  From the 
low-magnification micrographs, it could be seen that all types of scaffolds exhibited a 
smooth surface.  However, in high-magnification micrographs, many smooth dunes 
were revealed on the surface.  On the surface of pristine PCL scaffold (PCLP), smooth 
parabolic dunes were present (Figure 5.7A).  Besides these smooth parabolic dunes, 
there were some small dome dunes present on the surface of carboxylated PCL 
scaffold (PCLA) (Figure 5.7B).  After collagen immobilisation, these small dome 
dunes disappeared on the surface of collagen-immobilised, carboxylated PCL scaffold 
(PCLAC) (Figure 5.7C).  It was thus reasonable to speculate that the formation of 
smooth parabolic dunes on the surface of PCLP was due to uneven pressure generated 
on the scaffold surface during the fabrication process.  As for the small dome dunes on 
the surface of PCLA, they were due to the grafting of pAAc short chains.  In the mean 
time, the appearance of small dunes also revealed the absence of homopolymerisation.  
Eventually, these small dome dunes were embedded within the immobilised collagen 
on the surface of PCLAC. 
To further evaluate the effects of carboxylation and collagen immobilisation on the 
surface morphology of PCL scaffolds, AFM was used to examine the surface 
structures of the PCL scaffolds with different treatments by its high resolution.  
Figures 5.8A, B and C show the AFM images of pristine, carboxylated and collagen-
immobilised PCL scaffolds.  It could be seen that the surface morphology changed 
from a relative smooth surface of PCLP (Figure 5.8A) to a knotty surface (Figure 5.8B) 
associated with AAc grafting.  This could be due to the mechanism of carboxylation, 
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which was initiated by free radicals generated on the surface of pristine PCL scaffold.  
These free radicals then initiated the grafting of acrylic acid.  Subsequently, grafted 
polyacrylic acid chains formed their own territories and morphology on the surface of 
PCLA.  However, these territories could not be easy differentiated by SEM because 
their sizes are within sub-micron range.  In Figure 5.8C, dense fibrils were found on 
the surface of collagen-immobilised PCL scaffold, which might due to the fibrous 
structure of immobilised collagen molecules.  After collagen immobilisation, surface 
morphology reverted to a smooth surface.  As the territories previously on the surface 




Figure 5.7 SEM micrographs of the surfaces of: (A) pristine, (B) carboxylated, C) collagen-
immobilised, three-dimensional, porous, PCL scaffolds 
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Figure 5.8 AFM micrographs of the surfaces of: (A) pristine; (B) carboxylated; (C) collagen-
immobilised, three-dimensional, porous, PCL scaffolds 
5.3.1.3 Qualitative characterisation of surface modification by XPS and 
ToF-SIMS 
Figure 5.9A shows the XPS survey scan spectrum of pristine PCL scaffold.  The C 
1s and O 1s peaks which were present corresponded to binding energies of 284.6 eV 
and 532 eV [10,11].  With the carboxylated PCL scaffold (Figure 5.9B), its spectrum 
also showed the same C 1s and O 1s peaks as pristine PCL scaffold.  However, the 
relative intensities of C 1s and O 1s peaks varied after carboxylation — being greater 
than that in pristine PCL scaffold.  One possible explanation was the higher oxygen 
content in AAc than in PCL.  In contrast, a new peak corresponding to N 1s (at 400 eV 
binding energy) appeared on the spectrum of collagen-immobilised PCL scaffold 
(Figure 5.9C), which was due to the amino groups in the collagen molecules 
immobilised on the surface of PCL scaffold [36]. 
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Figure 5.9 XPS survey spectra of the surfaces of: (A) pristine; (B) carboxylated; (C) three-
dimensional, porous, collagen-immobilised PCL scaffolds 
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Similar results pertaining to N 1s core level spectra were observed in Figure 5.10 
for pristine, carboxylated and collagen-immobilised PCL scaffolds.  A peak 
corresponding to N 1s appeared only on the spectrum of collagen-immobilised PCL 
scaffold, suggesting that collagen molecules were successfully immobilised on the 
PCLAC surface [36]. 
 
Figure 5.10 XPS N 1s core level spectra of the surfaces of: (A) pristine; (B) carboxylated;  
(C) three-dimensional, porous, collagen-immobilised PCL scaffolds 
In Figure 5.11A, the C 1s core level spectrum of PCLP revealed three kinds of 
specific carbon species existing on the surface — namely aromatic carbon (C-C/H) at 
binding energy (BE) of 284.6 eV, carbon singly bonded to oxygen (C-O) at BE of 
286.2eV, and carboxyl carbon (C(=O)O) at BE of 288.5eV with an approximate area 
ratio of 5.2:2.0:1.0.  The results obtained were very close to the theoretical chemical 
structure of PCL, whereby the slight deviation was likely a result of adventitious 
hydrocarbon contamination.  In contrast, for PCLA (Figure 5.11B), an area ratio of 
5.0:1.0:1.2 was shown for the above species in the C 1s core level spectrum.  This 
implied that the C(=O)O species increased, while the C-O species decreased on the 
surface accordingly — a result consistent with the surface grafting of AAc. 
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Figure 5.11 XPS C 1s core level spectra of the surfaces of: (A) pristine; (B) carboxylated;  
(C) three-dimensional, porous, collagen-immobilised PCL scaffolds 
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After collagen immobilisation on PCLA by EDC/NHS chemistry, nitrogen atomic 
percentage on the surface of PCLAC was determined as 11 at%.  The nitrogen signal 
(specific to collagen molecules) appeared to confirm successful immobilisation of 
collagen molecules [36] on the surface of PCLAC.  Furthermore, after 2 days of 
thorough washing in deionised water with 0.05% Tween 20, the C 1 s core level 
spectrum of PCLAC (Figure 5.11C) could still be curve-fitted with two more new 
species — namely C-N species at 285.8 eV BE and C(=O)N species at 287.5 eV.  
These findings suggested that the immobilisation of collagen molecules on the surface 
of PCLAC was a direct result of covalent bond (peptide bond) formation between the 
activated carboxyl groups on the surface of PCLA and the amine groups of collagen 
molecules [36], which then affords good stability of specific interaction between cells 
or drugs and the polymer scaffold surface. 
Figure 5.12 shows the [O] and [N] distributions in the vertical direction to the 
surface of PCLP, PCLA and PCLAC, as examined by XPS sputtering.  The 
distributions of elements were localized by sputtering time as the latter was 
proportional to the sputtering distance from the surface of scaffolds.  Barring the 
initiate stage where a slight deviation was most probably a result of adventitious 
hydrocarbon contamination, surface concentration of [O] decreased in the following 
descending order: PCLAC> PCLA> PCLP.  This might be due to the different XPS 
sampling components present, namely collagen and pAAc for PCLAC, pAAc and PCL 
for PCLA, and PCL for PCLP, and [O] concentrations in the components: pAAc > 
collagen > PCL.  As for [N], it was present on the surface of collagen-immobilised 
PCL scaffold — though it decreased with time.  However, it was not present on the 
surfaces of PCLP and PCLA.  Presence of [N] might be due to collagen immobilisation. 
 Chapter 5  PCL-collagen hybrid scaffold 
 
 Page 5-30 
 
Aside from XPS analysis, ToF-SIMS was also used for further identification of 
elements and specific species on the surfaces of PCL scaffolds of different treatments 
in this study.  This was because its surface sensitivity was higher than that of XPS.  
Figures 5.13A, B and C show the ToF-SIMS spectra of pristine, carboxylated and 
collagen-immobilised PCL scaffolds.  Consistent with XPS results, a peak 
corresponding to C-N species at mass weight 26 appeared only in the spectrum of the 
surface of PCLAC, thereby confirming the successful collagen immobilisation process 
on the surface of PCL scaffold. 
 
 
Figure 5.12 [O] and [N] distributions in the vertical direction to the surfaces of: (A) pristine;  
(B) carboxylated; (C) collagen-immobilised, three-dimensional, porous, PCL 
scaffolds 
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Figure 5.13 ToF-SIMS spectra of the surfaces of: (A) pristine; (B) carboxylated; (C) collagen-
immobilised, three-dimensional, porous, PCL scaffolds 
5.3.1.4 Qualitative characterisation of surface modification by TBO and 
AO assays 
To quantitatively examine the distribution of chemical elements through the 
scaffold from interior to periphery during the surface grafting process, toluidine blue O 
and Acid Orange II assays were used to determine the surface concentrations of 
carboxyl and amine groups respectively.  These assays were used in conjunction with 
mechanical sectioning of surface-modified scaffolds by gamma or plasma induction 
(Figures 5.14A and B). 
TBO is a basic dye, which can form an ion complex with carboxylic group on the 
surface at pH 10 and which desorbs under acidic environment (50% acetic acid 
solution).  On the contrary, AO is an acidic dye which forms an ion complex with 
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amine group on the surface at pH 3 and which desorbs under pH 12.  The surface 
densities of carboxyl and amino groups were obtained by analysing the total amount of 
TBO or AO in the desorbed solution through colorimetry respectively.  The results 
showed concentration gradients for both carboxyl groups and amine groups on the 
surfaces of PCLA and PCLAC scaffolds whereby surface grafting was induced by 
plasma treatment (PCLAp and PCLACp), but not for scaffolds whereby surface 
grafting was induced by gamma irradiation (PCLAg and PCLACg), as seen in Figure 
5.14.  In particular, only 56% of carboxyl groups and 47% of amine groups appeared 
on the bottom surfaces of PCLAp and PCLACp scaffolds when normalised against the 
concentrations on the top surface of respective scaffold. 
 
 
Figure 5.14 Spatial distributions of: (A) carboxyl groups and (B) amine groups through the 
scaffolds (PCLA or PCLAC) determined by Toluidine blue O and Acid Orange assays.  
All data were normalised against the concentration on the top surface of each 
respective scaffold. 
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5.3.1.5 Characterisation of degradation on thermal and mechanical 
properties of PCL scaffolds after irradiation by tensile and DSC 
tests 
High-energy irradiation has been confirmed to cause degradation of polymers 
through crosslinking, chain scission or both depending chiefly on the chemical 
structures of the polymers [50,60,61].  The thermal and physical properties of PCL 
scaffolds after gamma irradiation were measured by tensile test and DSC in this study 
and illustrated in Figure 5.15 and Table 5.1. 
As shown in Figures 5.15A and B, both ultimate tensile strength and maximum 
elongation of PCL films were unstable under 0−60 kGy irradiation dose, and rapidly 
decreased after an absorbed irradiation dose of 60 kGy.  A possible explanation of this 
phenomenon might be the co-operational effects of crosslinking and scission of the 
polymer chains.  During the 0−20 kGy irradiation dose, scission of polymer chains was 
a dominant process, thereby resulting in decreased ultimate tensile strength and 
maximum elongation of PCL scaffold.  During the 20−60 kGy irradiation dose period, 
crosslinking occurred and lead to increase in ultimate tensile strength of PCL scaffold.  
When an absorbed irradiation dose of 60 kGy was exceeded, accumulated crosslinking 
hindered the movement of polymer chains, thereby resulting in decreased maximum 
elongation of PCL scaffold.  At the same time, accumulated polymer chain scission 
resulted in decreased ultimate tensile strength of PCL scaffold. 
Table 5.1 shows the effects of irradiation dose on thermal properties (i.e., Tm and 
Tg) and crystallinity (i.e., Xc) as measured by DSC. The results revealed a similar trend 
with that from tensile test. Xc increased during the 0−40 kGy irradiation dose.  This 
was because chain scission was the dominant process, and polymer crystallinity is 
inversely proportional to polymer chain length [62]. 
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From the consistent results between tensile test and DSC, it may be concluded that 
when irradiation dose absorbed was less than 60 kGy, only limited degradation was 
observed for the 3D, porous PCL scaffold used in this study regarding its physical and 









Figure 5.15 (A) Relationship between ultimate tensile strength of PCL films and gamma 
irradiation dose absorbed; (B) Relationship between maxiumum elongation of PCL 
films and gamma irradiation dose absorbed 
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Table 5.1 Thermal properties of PCL scaffold after various irradiation doses absorbed 
Irradiation dose (kGy) Tm (°C) Tg (°C) Xc (%) 
0 59.99 -59.24 65.28 
20 59.97 -58.70 69.03 
40 59.70 -58.97 70.07 
5.3.2 Characterisation of three-dimensional porous PCL-collagen 
scaffold 
5.3.2.1 Microstructure of three-dimensional porous PCL-collagen 
scaffold 
Microstructure of scaffolds is an important factor in tissue engineering.  Large 
pores in scaffolds contribute to better mass transfer for cell seeding and cell 
metabolism.  However, pores that are too large reduce the surface area for cell 
adhesion, as well as encapsulate cells within. 
The microstructure of PCL-collagen scaffold was characterised by SEM and a 
mercury porosimeter in this study.  Figure 5.16 shows the morphologies of the cross-
sections of collagen, pristine PCL and PCL-collagen scaffolds.  The following findings 
were apparent: 
(1) Collagen sponge generated by gamma irradiation consisted of many tortuous 
collagen strips with many widely dispersed, interconnected channels. 
(2) Pristine PCL scaffold was fabricated with a well-defined structure by aligned 
PCL microfibres. 
(3) Tortuous collagen strips were well adhered to the surface of aligned PCL 
microfibres in the PCL-collagen scaffold and interconnected channels were present 
inside the scaffold. 
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Pore size distribution, porosity and surface area of PCL-collagen scaffold were 
characterised by PASCAL 140 mercury porosimeter.  The porosity of PCL-collagen 
scaffold was 76%, indicating that the structure was highly porous. Total pore surface 
area was 0.01 m2 for each scaffold (10×10×6 mm) and mean pore diameter was 
136±33 μm.  A typical plot of pore diameter distribution is shown in Figure 5.17.  
SEM result revealed that collagen strips filled up the interspaces in PCL-collagen 
scaffold with many widely dispersed, interconnected channels. Thereby, results in 
increased surface area which is favourable for cell attachment.  It was also revealed 
that collagen adhered seamlessly to the surface of PCL scaffold.  Collagen appeared as 
integrated extensions of the PCL fibres as interconnected channels, thereby providing 
space for cell seeding and efficient mass transfer during cell culture. 
  
 
Figure 5.16 SEM micrographs of: (A) collagen sponge; (B) PCL; and (C) three-dimensional, 
porous, PCL-collagen scaffold 
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Figure 5.17 A typical pore size distribution of PCL-collagen scaffold as measured by mercury 
porosimeter.  Relative pore volume is defined as the percentage of volume for a 
specific pore diameter to total pore volume. 
5.3.2.2 Mechanical property of PCL-collagen scaffold 
The ability to resist physiological forces and prevent pores from collapsing of this 
scaffold was determined by a compression test in this study.  This is because 
compression modulus is commonly used as an indicator of a scaffold’s resistance 
against external forces [18]. 
Figure 5.18 shows the compression moduli of collagen sponge, PCL scaffold and 
PCL-collagen scaffold as measured by a Micro Tester. The compression modulus of 
PCL-collagen scaffold was 6.9 MPa, which was 600-fold to that of collagen sponge 
generated by gamma irradiation, and 1.5-fold greater than that of PCL scaffold.  The 
results implied that the mechanical property was much ameliorated in PCL-collagen 
scaffold due to the incorporation of aligned PCL microfibres in collagen sponge. 
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Figure 5.18 Compression moduli of (a)collagen sponge, (b)PCL scaffold and (c)PCL-collagen 
scaffold (n=5, mean±SD) 
5.3.3 Cell culture 
Surface chemistry of scaffolds (cell substrates) plays a pivotal role in altering cell 
attachment and metabolism in tissue engineering applications and biological responses 
elicited in these scaffolds are especially important as they reveal the clues that pave the 
way for tissue regeneration. 
In this study, hepatocytes — being anchorage-dependent cells that are highly 
sensitive to environmental cues [63] were seeded in the hybrid PCL-collagen scaffold.  
Thereafter, cell seeding, cell attachment and metabolism in this scaffold were 
examined.  Table 5.2 shows the cell seeding efficiencies in collagen sponge, PCL and 
PCL-collagen scaffolds.  Cell seeding efficiency was determined according to the 
equation below: 
Seeding efficiency (%) = 100 (No−Nr)/No 
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where No is the number of cells seeded in the scaffold, Nr is the number of cells which 
remained at the bottom of 24-well plate after 2 h of cell seeding (determined by a 
hemacytometer). 
Table 5.2 Seeding efficiencies of hepatocytes in different scaffolds 
 Collagen sponge PCL scaffold PCL-collagen scaffold 
Seeding efficiency 61% 6% 97% 
 
It was found that the efficiency of hepatocytes seeded in the PCL-collagen scaffold 
was the highest versus those in collagen sponge and PCL scaffold.  A possible 
explanation for this result is rendered scaffold-by-scaffold as follows: 
Â For collagen sponge, deformation of its geometry in cell seeding process — as 
a result of its poor mechanical property — resulted in hepatocytes leaking from the cell 
seeding medium, thereby causing low cell seeding efficiency [18]. 
Â For PCL scaffold, hepatocytes in the cell seeding medium leaked out through 
interspaces between the microfibres due to poor cellular affinity of PCL and large pore 
size of preformed PCL scaffold [36], thereby resulting in low cell seeding efficiency in 
PCL scaffold. 
Â For PCL-collagen scaffold, microstructures formed by combination of collagen 
strips and aligned PCL microfibres contributed to maintaining the medium where 
hepatocytes were contained as well as good cell attachment on the surface of collagen 
strips.  This implied that the PCL-collagen scaffold possessed the advantages of both 
PCL scaffold and collagen sponge, thereby increasing the cell loading capacity of this 
hybrid scaffold. 
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Figure 5.19 shows the morphologies of hepatocytes at 24 h after cell seeding in 
collagen sponge, PCL scaffold and PCL-collagen scaffold examined by SEM.  As 
predicted above, few hepatocytes were attached on the surface of PCL scaffold and 
were present in singles or in pairs.  Some hepatocytes also attached on the surface of 
collagen strips in collagen sponge in singles or in pairs.  In contrast, many hepatocytes 
attached on the surface of collagen strips or PCL microfibers in PCL-collagen scaffold 
as cell aggregates, which was consistent with the results of cell seeding efficiencies 
study with the same explanation. 
The number of hepatocytes attached in each scaffold at 24 h after cell seeding was 
evaluated in terms of DNA content by means of PicoGreen dsDNA Quantitation Kit.  
Figure 5.20 shows the number of hepatocytes attached to each scaffold.  Hepatocyte 
number in PCL-collagen scaffold was the highest probably due to these reasons: (1) 
Higher cell seeding efficiency in PCL-collagen scaffold than in collagen sponge and 
PCL scaffold; (2) RGD groups on the surface of collagen-grafted PCL microfibres 
promoted cell attachment [53,64]. 
The metabolism activity of hepatocytes cultured in each scaffold at 24 h after cell 
seeding was evaluated by AlamarBlue™ assay.  As cells being tested grow, innate 
metabolic activity results in a chemical reduction of AlamarBlue™.  Continued 
growth serves to maintain a reduced environment, while inhibited growth leads to an 
oxidized environment.  Reduction related to growth causes the reduction-oxidation 
indicator to change from oxidized form (non-fluorescent, blue) to reduced form 
(fluorescent, red). 
Figure 5.21 shows the reduction of AlamarBlue™ by hepatocytes cultured in 
collagen sponge, PCL scaffold and PCL-collagen scaffold.  All data were normalised 
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by the number of hepatocytes cultured in each scaffold.  The results indicated that the 
reduction of AlamarBlue™ by hepatocytes cultured in the PCL-collagen scaffold was 
much higher than in collagen sponge or PCL scaffold.  This result could be attributed 
to a few factors: (1) Biocompatible surface of PCL-collagen scaffold promoted the 
metabolism activity of cell, and (2) The best mass transfer among 3 kinds of scaffolds, 
which benefited from interconective channels microstructure and appropriate 
mechanical strength, resulted in the best cell metabolism activity.  
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Figure 5.19 SEM micrographs of the morphologies of hepatocytes in: (A) collagen sponge; (B) 
PCL; and (C) PCL-collagen scaffolds after 24 h of cell seeding 
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Figure 5.20 Number of hepatocytes attached in different scaffolds at 24 h after cell seeding 
(normalised by the number of cells seeded) (n=3, mean±SD) 
 
Figure 5.21 Reduction of AlamarBlue™ by hepatocytes cultured in different scaffolds at 24 h 
after cell seeding (n=3, mean±SD) 
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5.4 CONCLUSIONS 
A new type of 3D, porous, hybrid, polymeric scaffold with a relatively well-
defined structure was developed, which was accompanied with a stable immobilization 
of collagen molecules on the surface from interior to periphery at a uniform density.  
The novel hybrid scaffold embodied the advantages of both collagen sponge and PCL 
scaffold, thereby resulting in good cellular affinity with appropriate mechanical 
property of this scaffold.  XPS results confirmed that collagen was successfully grafted 
onto the surface of PCL scaffold.  TBO and AO assays further proved the uniformity 
of surface modification.  Tensile test and DSC results indicated low-degree 
degradation of PCL scaffold by gamma irradiation.  The compression test indicated 
that this hybrid PCL-collagen scaffold had good mechanical properties.  In terms of 
microstructure, pore size distribution revealed that this hybrid scaffold mimicked the 
structure of native ECMs.  Cell culture studies with primary rat hepatocytes 
demonstrated high cell seeding capacity and high metabolism activity of hepatocytes 
cultured in this scaffold.  Based on the results obtained, this 3D, porous, hybrid, 
polymeric scaffold with a relatively well-defined structure indeed proved to have 
potential applications in liver tissue engineering — a result of possessing the 
advantages of both natural and synthetic polymeric scaffolds. 
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6.1 INTRODUCTION 
Currently, much attention has been drawn to the development of BAL devices, 
which is intended to act as a “bridging” device that would temporarily provide normal 
liver function for patients with acute liver failure.  Alternatively, it also can be used as 
a long-term support to facilitate liver regeneration for patients with chronic liver 
failure as same as dialysis support for a failing kidney [1−5].  However, wholly 
artificial systems have not bee proven efficacious yet.  One significant challenge that 
needs to be overcome is the mass transfer limitation in BAL devices.  This drawback is 
exacerbated by the mass of hepatocytes (at least 1010) that must be packed in BAL 
devices as a minimum requirement to replace the hepatic functions of patients with 
liver failure [5,6]. 
Most BAL devices are designed to adopt convective transport to overcome the high 
mass transfer resistance for delivery of nutrients or oxygen to and removal of wastes 
from the viable cells within the cell culture environment.  It has been found that when 
hepatocytes were cultured under perfusion conditions, new tissue formation and high 
expression of hepatic functions were yielded [7−11].  In this connection, hollow fibre 
and membrane perfusion culture systems have been extensively studied due to their 
relatively high mass transfer coefficients [6], but low cell load capacity hindered their 
applications.  Perfused Beds/Scaffolds culture systems can harbour cell loading 
capacities that are 10−100 times higher than that of hollow fibre culture system [12].  
But, in most of these systems, mass transfer efficiency was low [13].  Although 
convection flow induced by perfusion culture dominates the external transport of tissue 
constructs in BAL devices, diffusive transport is still the predominant factor in mass 
transfer inside tissue constructs.  The effective diffusion coefficient is usually much 
lower due to the high tortuosity within tissue-engineered constructs.  As a result, cells 
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are observed to grow along the periphery of the tissue constructs such that the inner 
core of the construct usually suffers asphyxia.  Cells lying in the inner core layers also 
do not experience flow-induced mechanotransduction.  The construct surface 
experiences greater unremitting flow and shear than the inner core.  A gradient in the 
hemodynamic environment is thus created across the construct, which is typically not 
experienced by cells in vivo [14]. 
In living tissues, a blood capillary supplies nutrients to tissues approximately 100–
200 μm away [15].  Most liver tissue constructs in Perfused Beds/Scaffolds culture 
systems are beyond 200 μm in thickness to minimize the cell loading process for tissue 
constructs.  However, thicker or large tissue constructs have been shown to have 
higher mass transfer resistance for nutrients, oxygen and waste products as it is 
proportional to the transport distance [6].  Thus, mass transfer limitation through a 
tissue construct in Perfused Beds/Scaffolds culture system is a critical challenge that 
must be overcome.  This is to enable it to become an efficient BAL device, in which a 
mass of hepatocytes can survive throughout the entire construct with highly effective 
hepatic functions for long-term culture.  Recently, a novel intra-tissue perfusion (ITP) 
system using an array of micron-sized porous needles to deliver nutrients into thick 
liver slices was developed in our laboratory [13]. 
Based on the benefit from the above technique, and with microcirculation 
incorporated into PCL-collagen scaffolds by generating a stable interconnected 
microstructure described in Chapter 5, a novel Perfused Beds/Scaffolds culture 
system was proposed in this chapter.  As such, the objectives of this study were: 
(1) Investigate the feasibility of applying a structure-defined PCL-collagen scaffold 
in ITP system to perfusion-culture liver tissue construct. 
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(2) Investigate the effects of intra-tissue perfusion on hepatic functions of 
hepatocytes cultured in the above scaffold. 
In this chapter, we designed an array of micron-sized needles, which were 
embedded in a polycarbonate platform to deliver nutrients and remove metabolites by 
interfacing with the angioarchitecture of flow paths in vivo.  Hepatocytes were seeded 
in PCL-collagen scaffolds, which were penetrated with microporous need array for 
perfusion culture.  Hepatocytes cultured under intra-tissue perfusion in those hybrid 
scaffolds exhibited higher levels of differentiated functions such as albumin secretion 
and urea synthesis versus those cultured under perfusion only.  This thus implied its 
potential applicability in BAL devices and cell-based therapies. 
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6.2 EXPERIMENTAL DETAILS 
6.2.1 Scaffold preparation 
PCL-collagen scaffolds were fabricated as described in Chapter 5.  The process 
included immobilisation of collagen onto the surface of the 3D, porous structure 
defined PCL scaffolds and lyophilisation.  Prior to cell seeding into the scaffolds, all 
the scaffolds were sterilised by exposure to a 60Co source irradiator until a total dose of 
25 kGy was achieved. 
6.2.2 Perfusion bioreactor system assembly 
A multi-needle perfusion bioreactor was designed to conduct ITP culture.  Detailed 
mechanical drawings of the bioreactor design are illustrated in our pervious study [13].  
A schematic diagram of the experimental set-up is shown in Figure 6.1.   
 
Figure 6.1 Schematic diagram of ITP system: (A) Top cover; (B) Needle platform;  
(C) Adjustable brace; (D) Bottom chamber; (E) Tissue construct 
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This ITP perfusion bioreactor comprised four components as explained below: 
(1) Top cover (Figure 6.2A): consisted of needle chamber and bioreactor inlet. 
(2) Needle platform (Figure 6.2B): a platform for stainless steel porous needle 
array.  Stainless steel, porous needles were fabricated with these precise dimensions: 
300 μm external diameter, 150 μm internal diameter, 8 mm length and with 50-μm 
microholes along the length of the needles at an interval of 660 μm (Vita Needle 
Company Inc., Needham, MA). 
(3) Adjustable brace (PEEK) (Figure 6.2C): a component to hold the tissue 
construct in place.  It consisted of five supporting struts with a fixed plate and pressure 
plate.  A Teflon screw controlled the pressure plate position and allowed culturing of 
tissue constructs with different thicknesses. 
(4) Bottom chamber with bioreactor outlet (Figure 6.2D): to ensure that tissue 
construct is immersed in perfusion medium. 
 
Figure 6.2 Bioreactor components: (A) Top cover; (B) Needle platform; (C) Adjustable brace; (D) 
Bottom chamber 
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The perfusion chamber was connected to a closed-loop perfusion set-up as 
illustrated in Figure 6.1.  A multi-channel peristaltic pump (IPC-N-12, Ismatec, 
Glattbrugg, Switzerland) was used to drive the perfusion medium in Tygon® dual-stop 
pump tubings (1.02 mm ID, Glattbrugg, Switzerland) and Silastic® laboratory tubings 
(1.02 mm ID, Dow Corning Corp., MI, USA).  Perfusion medium was driven from a 
reservoir into the tissue construct via the micron-sized needles immobilised in the 
needle platform.  The medium was then collected in the bottom chamber and re-
circulated back to the reservoir.  Flow rate was controlled via a digital controller on the 
pump. 
6.2.3 Cells isolation and culture 
Adult male inbred Wistar rats (Animal Holding Unit, National University of 
Singapore, Singapore) weighing 200 to 300 g were used in this study.  Housing and 
feeding were done according to NIH and NACLAR guidelines for the care of 
laboratory animals.  All experimental protocols employed in this study were approved 
by the IACUC Committee of the National University of Singapore. 
Hepatocytes were harvested by a two-step in situ collagenase perfusion method as 
described in Chapter 3.  The viability of hepatocytes harvested was determined to be 
90–95 % based on the conventional trypan blue exclusion test. 
6.2.3.1 Hepatocyte seeding and culture 
PCL-collagen scaffolds were seeded with 0.3 mL of hepatocyte suspension at a 
density of 6×106 cells/mL of culture medium via injection with a 25G hypodermic 
needle.  Cell-seeded scaffolds were incubated in a CO2 incubator to allow hepatocyte 
attachment in the scaffolds.  After 1 h incubation, the culture medium was added and 
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covered the scaffold. This was incubated for another 3 h.  Cells that did not attach to 
the scaffolds were collected and counted to determine the cells seeding efficiency. 
For intra-tissue perfusion culture, hepatocyte-seeded scaffold was held by the 
porous needle array in needle platform.  Subsequently, it was mounted in the 
bioreactor and perfusion culture with 14 mL of perfusion medium.  Flow rate was 
increased from 0.1 mL/min to 0.5 mL/min at an increment of 0.1 mL/min every 2 mins 
to reduce damage associated with burst of pressure change to the cells.  The perfusion 
medium used was Williams’ E medium supplemented with 10 mmol/L nicotinamide 
(Sigma−Aldrich), 0.2 mmol/L ascorbic acid 2-phosphate (Sigma−Aldrich), 20 ng/mL 
epidermal growth factor, 20 mmol HEPES (Gibco),0.5 μg/mL insulin, 0.1 μmol/L 
dexamethasone, 100 U/mL penicillin G and 100 μg/mL streptomycin.  Cell-seeded 
constructs cultured in bioreactor without porous needles were used as controls.  All 
cultures were incubated at 37°C, 95% O2 and 5% CO2 as shown in Figure 6.3.  
Perfusion medium was changed every 2 days.  Albumin secretion and urea production 
in the culture medium were measured every 48 h. 
 
Figure 6.3 Apparatus of intra-tissue perfusion system 
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6.2.4 Cell morphology characterisation by scanning electron 
microscopy 
The morphology of hepatocytes in the scaffolds was characterized by scanning 
electron microscopy (SEM).  Details of sample preparation and SEM settings were the 
same as those described in Chapter 3. 
6.2.5 Cell morphology characterisation by micro-XCT 
The morphology of hepatocytes in the scaffolds was further characterised by 
micro-XCT, a multi-scale CT system (Xradia Inc., Concord, CA, USA).  This is a non-
invasive method used to visualise internal morphology. 
Samples were fixed with glutaraldehyde (3% in PBS) for 30 mins.  After repeated 
rinsing, samples were further fixed with an aqueous solution of osmium tetraoxide 
(OsO4) (1%) at 4°C for 30 mins.  The samples were washed with distilled water and 
dehydrated through an ethanol series (25, 50, 70, 90, 95 and 100%) before being dried 
using hexamethyldisilazane [1].  Samples were characterised by micro-XCT directly 
with 0.7 µm resolution of tungsten X-ray source (150 KV, 75W), and 3D images were 
acquired through reconstruction by 3D tomographic reconstuctor (Xradia Inc., 
Concord, CA, USA). 
6.2.6 Cell viability characterisation by confocal laser scanning 
microscopy (CLSM) 
The viability of hepatocytes cultured in PCL-collagen scaffolds was characterised 
by LIVE/DEAD® Cell Vitality Assay Kit (L34951) (Molecular Probes, Invitrogen, 
Singapore).  Samples with hepatocytes were rinsed by PBS to remove nonattached 
cells. Viable cells were stained red by the reduction of C12-resazurin to fluorescent C12-
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resorufin at a concentration of 500 nM in perfusion medium.  Dead cells were stained 
green by SYTOX Green at a concentration of 10 nM.  Samples were incubated at 37°C 
with both dyes for 30 mins.  The samples were washed twice in PBS, and sectioned 
before viewing the sample sections under a confocal laser microscope (Olympus IX70-
HLSH100 Fluoview). 
6.2.7 Hepatocyte function assay 
Hepatic functions include albumin secretion and urea syntheses were evaluated in 
this study.  Albumin secreted by hepatocytes cultured in the scaffolds was analysed by 
sandwich enzyme-linked immunosorbent assay (ELISA) and a urea colorimetric assay 
kit (Stanbio Laboratory, Boerne, TX, USA).  Sample preparation and assay details of 
assays were the same as those described in Chapter 4. 
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6.3 RESULTS AND DISCUSSION 
6.3.1 Cell morphology and viability 
The morphologies of hepatocytes in the centre section (2 mm thick) of PCL-
collagen scaffolds with or without intra-perfusion were examined by SEM after 24 h 
culture, as shown in Figure 6.4. 
 
Figure 6.4 SEM micrographs of hepatocytes cultured in PCL-collagen scaffold: (A) without 
intra-tissue perfusion; (B) with intra-tissue perfusion 
From the above images, it was clearly shown that hepatocytes were dispersed 
throughout the scaffold, being attached on the surface of either tortuous collagen strips 
or PCL microfibres with their spherical shape under both culture conditions.  However, 
there were more hepatocytes present as aggregates in the scaffold with intra-tissue 
perfusion culture.  On the other hand, in the scaffold without intra-tissue perfusion, 
less hepatocytes were present in singles or in pairs. 
Alternatively, micro-XCT is a non-invasive tool that can visualise the real 
morphology of cells and the interactions between cells and biomaterials without 
destroying the scaffolds by sputtering and sectioning, which may introduce artifacts in 
images [1].  Figures 6.5A and B show the 3D micro-XCT images of the morphologies 
of hepatocytes after 24 h of culture with and without intra-tissue perfusion, which 
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further confirmed the results as those revealed by SEM.  In other words, a mass of 
hepatocytes were well attached and kept their phenotype in PCL-collagen scaffolds. 
 
Figure 6.5 Micro-XCT 3D images of hepatocytes cultured in PCL-collagen scaffold: (A) without 
intra-tissue perfusion; (B) with intra-tissue perfusion 
Additionally, from the above SEM and micro-XCT results, it should be highlighted 
that hepatocytes were well dispersed throughout the whole PCL-collagen scaffold.  
This showed that the scaffold microstructure formed by collagen strips and PCL 
microfibres was not only favorable for culturing, but also able to hold the cultured 
hepatocytes in without being washed out by ITP perfusion. 
More hepatocytes were present in PCL-collagen scaffold with intra-tissue 
perfusion than that without.  This was due to high cell viability within the scaffold 
under intra-tissue perfusion culture, which was illustrated by confocal laser scanning 
microscopy.  Figures 6.6A and B show the viabilities of hepatocytes after 24 h of 
culture in the center section of PCL-collagen scaffolds with and without intra-tissue 
perfusion.  With metabolically active cells, the assay was based on the reduction of 
C12-resazurin to red-fluorescent C12-resorufin.  For cells with compromised plasma 
membrane, the assay was based on the uptake of cell-impermeant, green-fluorescent 
SYTOX® nucleic acid stain. 
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Upon comparing the images, there were more green and less red signals in Figure 
6.6A than in Figure 6.6B.  This indicated that without intra-tissue perfusion, the 
viability of hepatocytes in PCL-collagen scaffold was significantly lower.  Hepatocytes 
might have died due to lack of mass transfer, and subsequently detached from the 
scaffold surface.  This suggested that ITP improved mass transfer into the inner core of 
the tissue construct, thus preventing cells from asphyxia. 
 
Figure 6.6 Viability of hepatocytes cultured in PCL-collagen scaffolds imaged by CLSM after 24 
h of cell seeding: (A) without intra-tissue perfusion; (B) with intra-tissue perfusion.  
C12-Resazurin/SYTOX Green was used to assess cell viability.  Viable cells were 
stained red and nuclei of dead cells were stained green. 
6.3.2 Hepatocyte functions 
To verify the effect of ITP on maintenance of hepatic functions in PCL-collagen 
scaffold, albumin synthesis and urea production rates were investigated.  Figures 6.7A 
and B show the albumin synthesis and urea production rates of hepatocytes in PCL-
collagen scaffolds over a period of 9 days.  As described in Chapter 3, all data were 
normalised by the hepatocyte number calculated from the DNA content in each 
scaffold. 
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Throughout the 9 days of culture, albumin synthesis activity in the scaffold 
cultured in the ITP system was significantly higher than that under perfusion condition 
(about two folds higher on day 5).  From day 2 to day 6, the level of albumin synthesis 
function under ITP increased.  Then from day 6 to day 8, there was a significant drop 
in albumin synthesis function.  Under perfusion culture condition, similar trends of 
increase were observed for albumin synthesis function from day 2 to day 4, and then 
decrease from day 6 to day 8. 
For urea production, a similar trend as that of albumin synthesis function was 
observed (Figure 6.7B).  Under perfusion culture, urea synthesis function increased 
from day 1 to day 5, and then dropped significantly after day 5.  Under ITP perfusion 
culture, a significant drop in urea synthesis function was also observed from day 5.  
Nonetheless, urea synthesis function was maintained at a significantly higher level 
under ITP culture than under perfusion culture condition during the whole 9-day 
period. 
The above hepatic function results were consistent with previous studies on 
hepatocyte perfusion culture [9,17].  This implied that hepatocytes cultured under ITP 
condition would enhance the maintenance of hepatic functions of hepatocytes, which 
was an encouraging finding for development of efficient BAL devices. 
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Figure 6.7 Functions of hepatocytes under intra-tissue perfusion culture or perfusion culture 
during 9-day culture: (A) Albumin secretion rates of hepatocytes; (B) Urea 
production rates of hepatocytes.  All data were quantified and normalised against the 
DNA content in each scaffold.  Data are represented as mean±SD (n=3). 
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6.4 CONCLUSIONS 
In this study, the feasibility of applying ITP to culture hepatocytes in a large PCL-
collagen scaffold was investigated.  The hepatocytes cultured under ITP condition 
exhibited high attachment and viability relative to that under perfusion condition alone.  
In the latter condition, hepatocytes were seeded in scaffolds without the porous needles 
penetrating through.  Furthermore, the ITP system maintained the differentiated 
hepatic functions at significantly higher levels than under the perfusion culture.  These 
results implied the improvement of the mass transfer of nutrients, oxygen and waste 
exchange by ITP system, thereby improving the maintenance of liver-specific 
functions of hepatocytes cultured in a thick scaffold. 
In terms of clinical application, a biodegradable tissue scaffold in conjunction with 
an ITP system will enable the development of highly functional BAL devices.  This 
would mean high cell loading capacity, consistent delivery of nutrients and efficient 
waste exchange throughout the whole scaffold wherein the cells were cultured, which 
in turn results in a mass of highly functional, viable hepatocytes for long-term 
cultivation in vitro. 
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7.1 CONCLUSIONS 
In the development of effective BAL devices and reliable surrogate tissues for liver 
cell-based therapies, a significant challenge lies in the design of a functional 
scaffold/substrate that could support the maintenance of a mass of highly functional 
and viable hepatocytes in vitro.  In our bid to overcome this challenge, two types of 3D 
hybrid scaffolds were developed.  For the first hybrid scaffold, it was achieved by 
crosslinking collagen with random-blended, surface-modified PLGA fibres.  For the 
second hybrid scaffold, it was achieved via gelation of collagen in a structure defined 
PCL scaffold.  Nonetheless, these scaffolds demonstrated high efficacy in supporting 
the coculture of hepatocytes with hepatic stellate cells HSC-T6 as well as ITP system 
for hepatocyte culture.  A quick overview of the key accomplishments in this study are 
summarised as follows: 
(1) Fabrication of three-dimensional, hybrid PLGA-collagen scaffold.  This was 
achieved by grafting the surface of hydrolysed PLGA fibres with collagen using 
EDC in combination with NHS. Infiltrated collagen between the PLGA microfibres 
was lyophilised followed by stabilisation with crosslinking.  The scaffold was thus 
composed of collagen-grafted microfibres (average fibre diameter: ca. 11 μm) and 
collagen strips embedded in the interspaces between the microfibres.  Porosity of 
scaffold was 81% and total surface area of each scaffold was 0.032 m2 (9×18×3 
mm).  The compression test indicated that the average compression modulus was 
0.134 MPa — which was 50-fold higher than that of commercially available 
collagen sponges.  Moreover, pore size distribution revealed a diversity of pores 
sizes, thereby mimicking the physical structure of native ECMs.  This is an 
important characteristic that augers well for cell cultivation because biological 
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tissues consist of well-organised, hierarchical, fibrous structures realigned from 
nanometre to millimetre scale, and tissues are organised into organs. 
As for cell culture studies with primary rat hepatocytes, good attachment and 
high metabolic function were favourably exhibited by the hepatocytes cultured in 
this scaffold.  Indeed, the results obtained in this study clearly indicated that this 
hybrid scaffold inherited the advantages of both PLGA and collagen in a single 
scaffold.  On this score, this hybrid scaffold is a potential candidate for tissue 
engineering.  However, it should also be mentioned that its applicability might be 
hampered by its undefined structure. 
(2) Feasibility of PLGA-collagen scaffold in liver tissue engineering.  In this 
study, a new perfusion bioreactor with two separate compartments was developed 
for the serial perfusion coculture of hepatocytes and the supporting HSC-T6 cells 
in this 3D PLGA-collagen scaffold.  Differentiated functions of the hepatocytes in 
this bioreactor were maintained at a higher level versus the monoculture control.  
In other words, scaffolds used in this dual-compartment perfusion bioreactor 
enabled independent control of supporting cells; thereby possibly enabling local 
environments to be “tailor-made” or customised for different applications in BAL 
devices or cell-based tissue construct transplantation therapies. 
(3) Fabrication of well-defined, structured, porous PCL-collagen scaffold.  To 
overcome the drawback of undefined structure of PLGA-collagen scaffolds, a new 
type of 3D, porous, hybrid polymeric scaffold with a relatively well-defined 
structure was developed.  Moreover, immobilised collagen formed a uniform and 
stable bioactive layer on its surface from the interior to periphery.  In other words, 
this preformed, 3D scaffold not only adequately addressed the concern about 
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structures with well-defined architecture in tissue engineering, it also showed that 
uniform surface modification of large tissue constructs could be performed 
successfully. 
In terms of internal microstructure, average porosity was 76% and total 
surface area of each scaffold was 0.01 m2 (10×10×6 mm).  These values were 
relatively low when compared against the PLGA-collagen scaffold, chiefly due to 
the larger diameter of PCL microfibres.  Compression test indicated that the 
average compression modulus of this new scaffold was 6.9 MPa — which was 
600-fold greater than that of collagen sponge polymerised by gamma irradiation.  
Characterisation of mechanical and thermal properties confirmed the low degree of 
degradation of PCL scaffold initiated by gamma irradiation.  Therefore, similar to 
PLGA-collagen scaffold, this new hybrid scaffold also embodied the advantages of 
both collagen sponges and PCL scaffold, thereby resulting in good hepatocyte 
attachment and the hepatocytes expressing high metabolism activity. 
(4) Feasibility of PCL-collagen scaffold in liver tissue engineering.  To 
investigate the effects of intra-tissue flow perfusion, hepatocytes were cultured in 
vitro in the hybrid PCL-collagen scaffold in an ITP system.  It was found that ITP 
improved the maintenance of differentiated functions for the hepatocyte culture in 
PCL-collagen scaffold at a higher level as compared to perfusion culture only.  
Furthermore, hepatocytes cultured under ITP condition exhibited good attachment 
and high viability as compared to under perfusion condition alone. 
In other words, it has been shown that a preformed, structured, well-defined, 
polymeric tissue scaffold could be synchronised into the ITP system.  This implied 
that highly functional BAL devices could be developed in the foreseeable future as 
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a result of high cell loading capacity, consistent delivery of nutrients and efficient 
waste transfer. 
In conclusion, two different hybrid scaffolds were successfully developed: an 
unstructured one comprising random-blended, collagen-grafted PLGA microfibres and 
crosslinked collagen (PLGA-collagen), versus a structured and well-defined one which 
comprised gelated collagen and a collagen-grafted scaffold preformed by FDM and 
gamma-induced collagen polymerisation (PCL-collagen).  Most significantly, the 
facile and effective approaches rendered in this thesis successfully synchronised 
natural and synthetic polymers, as well as perfusion-based hepatocyte coculture with 
HSC-T6 and ITP.  As such, the herein-developed scaffolds were able to maintain a 
mass of highly functional, viable hepatocytes which could preserve their differentiated 
functions for long-term cultivation — thereby paving the way for efficient 
development of BAL devices and cell-based tissue construct transplantation therapies 
in the future. 
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7.2 RECOMMENDATIONS FOR FUTURE WORK 
7.2.1 Liver tissue engineering 
In the past few decades, various bioartificial liver models had been proposed, such 
as hollow fibre cartridges [1], perfused packed bed/scaffold columns [2−4] and flat-
plate devices [5].  Amongst which, the hollow fibre cartridge model was the most 
promising candidate for bioartificial liver because of numerous apparent advantages: 
(1) Large surface area-to-volume ratio with improved mass transfer of nutrients, 
oxygen and metabolites; (2) Immunoisolation function of hollow fibre membrane; and 
(3) Prevention of cell damage owing to shear stress through membrane barrier [6]. 
Despite the many advantages of hollow fibre bioartificial liver, it has its share of 
limitations too.  Its major deficiency lies in its limited mass transfer function due to 
adsorption of proteins in plasma/culture medium onto the surface of hollow fibre 
(surface fouling), thereby reducing the mass transfer efficiency drastically.  Although 
changing the flow configuration will help to solve the fouling problem to some degree 
[7], it is restricted by shear stress generation on the cell membrane which will 
influence the viability of hepatocytes in bioartificial liver. 
Another deficiency lies in the poor cell attachment in hollow fibre bioartificial liver 
[8].  Typically, most hollow fibre surfaces are designed to be inert to avoid protein 
adsorption.  However, primary hepatocytes are anchorage-dependent cells, which 
means that cell-substrate interaction is needed to stimulate hepatocyte attachment [9].  
However, adhesive substrate coatings which are intended to improve cell attachment 
and maintenance of functions — also reduce the viability of hepatocytes cultured on 
hollow fibre surfaces as a result of high resistance to mass transfer [10]. 
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The third deficiency lies in its inability to maintain a mass of hepatocytes in 
bioartificial liver.  This is chiefly due to the low surface-to-volume ratio of hollow 
fibre membrane, thereby resulting in low cell loading capacity of hollow fibre 
bioartificial liver.  It should be noted that in order to support a patient’s failing liver; at 
least 1010 hepatocytes must be packed in the bioartificial liver. 
To overcome the above limitations of hollow fibre bioartificial liver, we hereby 
propose a novel bioartificial liver model which decouples cell cultivation from the 
hollow fibre compartment based on the research results in this study.  Hepatocytes will 
be cultured in the cell-scaffold compartment with intra-tissue perfusion micro needles 
instead of with the hollow fibre.  Then, components such as protein, toxic and waste 
materials will be exchanged between the culture medium and blood stream in another 
compartment (hollow fibre compartment).  Figures 7.1 to 7.3 show the comparisons 
between this proposed configuration and the conventional configuration.  Indeed, the 
abovementioned drawbacks of traditional hollow fibre bioartificial liver will be 
completely or partially solved by this type of decoupled bioartificial liver. 
 
Figure 7.1  Schematic diagram of current bioartificial liver configuration 
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Figure 7.2  Schematic diagram of proposed bioartificial liver configuration 
 
Figure 7.3  Schematic diagram which compares mass transfer mechanisms in BAL 
As for the advantages of the herein-proposed bioartificial liver configuration, they 
are: (1) Dramatically improved cell attachment and cell function by means of surface 
modification without compromising mass transfer efficiency of hollow fibre;  
(2) Reduced surface fouling due to surface-modified hollow fibre being rendered more 
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inert, thereby preventing protein adsorption; (3) Able to reduce fouling potential with 
wider range of materials selection for hollow fibre fabrication, as well as greater 
flexibility in changing flow configuration and flow rate, without being unduly 
concerned about attachment and damage of hepatocyte culture in different 
compartments;  
(4) Convenient optimisation of mass transfer between cell compartment and blood 
plasma compartment by flow rate and transmembrane pressure without being unduly 
concerned about damaging hepatocytes cultured in different compartments. 
For our recommended model, the neutralisation of patient’s plasma will be carried 
on in dialyser A, detoxification of patient’s plasma in dialyser B, detoxification of 
culture medium in dialyser C.  In the bioreactor, cells will be cultured in scaffolds. In 
dialyser A, cell culture medium will pass through the inside of hollow fibre while 
plasma will flow through the shell compartment.  Medium pressure will be higher than 
that of plasma and will create a pressure gradient between plasma and culture medium.  
In dialyser B, plasma will pass through the inside of hollow fibre while cell culture 
medium will flow through the shell compartment.  Plasma pressure will be higher than 
that of culture medium and will create a pressure gradient between plasma and culture 
medium.  In dialyser C, culture medium will flow through the inside of hollow fibre 
while plasma will occupy the shell compartment.  Pressure of culture medium will be 
higher than that of plasma.  Through this arrangement, mass transfer between cell 
culture medium and plasma will be driven by both pressure gradient and concentration 
gradient.  Conversely, in the traditional bioreactor, pressure is restricted by that which 
is generated on the cell membrane. 
In summary, all the abovementioned advantages are a result of decoupled cell 
cultivation with mass exchange.  This notion was conceptualised based on two 
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premises: the dual-compartment bioreactor which isolated the culture environment in 
different chambers, and the novel 3D scaffolds wherein a mass of highly functional 
hepatocytes were cultured.  Indeed, this new bioartificial liver configuration and the 
novel scaffolds make it feasible to solve fluid-mechanical and biological problems 
separately. 
7.2.2 Bone tissue engineering 
The novel scaffolds developed in this study can be used not only for liver tissue 
engineering, but also for bone tissue engineering.  PCL scaffolds have been 
extensively studied for bone tissue engineering [11−14].  It should be highlighted that 
in three-dimensional, porous, polymeric scaffolds, surface chemistry plays a pivotal 
role in altering cell morphology and differentiation.  The biological responses elicited 
in these scaffolds are especially important as they reveal the clues that pave the way 
for tissue regeneration [15,16]. 
We have done some preliminary experiments on bone marrow stromal cells 
(BMSC) osteogenic differentiation using three-dimensional, porous, collagen-
conjugated PCL scaffolds.  Our study results revealed that be it culturing with or 
without collagen conjugation, BMSCs expressed cell adhesion at 1.5 hours after cell 
seeding, as shown in SEM images (Figures 7.4A and B).  However, for cells cultured 
in the controls, a cuboidal cell shape was presented after 3 days — as opposed to the 
flattened cell shape of cells cultured in the scaffolds with surface grafting (Figures 
7.4C and D).  Furthermore, the von Kossa staining images showed that there were 
more mineral deposits for cells cultured in the scaffold with surface grafting (Figure 
7.5) as compared to the control. 
 Chapter 7  Conclusions and recommendations
 
 Ver 0.3, Page 7-10 
 
 
Figure 7.4 SEM micrographs of BMSC culture on surfaces of: (A) PCL and  
(B) collagen-conjugated PCL scaffolds after 1.5 h of cell seeding; (C) PCL and  
(D) collagen-conjugated PCL scaffolds after 24 h of cell seeding 
 
Figure 7.5 Mineral deposition as assessed by von Kossa staining for BMSCs cultured on the 
surfaces of: (A) PCL scaffold and B) collagen-conjugated PCL scaffold after 1 week 
of culture in osteogenic induction medium 
The results obtained seemed to imply that when cultured on the surface of PCL 
scaffold with collagen conjugation, the cells possessed a shape that was more spread 
out than those cultured on the control and accompanied with more mineral deposits.  
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These results were consistent with recent studies which have provided a better 
understanding on cell shape control and osteogenic differentiation of BMSCs through 
focal adhesion kinase (FAK) signalling pathway by integrin clustering mediation 
[17−19].  After cell adhesion on RGD rich extracelluar matrix - collagen, integrin 
clusterings on cell membrane are induced, which both trigger pFAK activation to 
initiate ERK signalling pathway which stimulates osteogenic gene expression [20], and 
form stronger cell-substratum interaction to facilitate cell spreading [21]. 
At this juncture, it must be put into perspective that the above analysis was only a 
proffered conclusion.  To arrive at a more concrete conclusion, further studies that 
entail more detailed investigations are essential and mandatory. 
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